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Abstract
Mutations in the human ATRX gene cause alpha-thalassemia mental retardation X-linked
(ATR-X) syndrome associated with severe cognitive and behavioural deficits, seizures,
and microcephaly, indicating that ATRX is an essential factor in the normal development
of the central nervous system (CNS). Conditional inactivation of Atrx in the developing
mouse forebrain leads to a reduction in cerebral cortical size, elevated levels of p53dependent neuronal apoptosis, and cortical dysgenesis, confirming a broad requirement
for Atrx in mammalian brain development. The mammalian ATRX gene encodes a
member of the Snf2 family of chromatin remodeling proteins and was originally defined
as a transcriptional regulator, however at the commencement of this research project no
ATRX gene targets had yet been linked to CNS development. In contrast, ATRX is
highly enriched at pericentromeric heterochromatin in somatic and germ cells where it is
required for normal meiotic cell division, however a requirement for ATRX in mitotic
cell division has not yet been reported. In chapters two and three, I investigated this by
using RNAi to deplete ATRX levels in a human cancer cell line and found that cells
depleted of ATRX showed mitotic dysfunction including chromosome congression and
alignment defects and chromosome bridging, and reduced centromeric sister chromatid
cohesion and elevated levels of cytokinetic failure and multinucleation. Furthermore,
mitotic neuronal progenitor cells from the embryonic Atrx-null mouse forebrain display
mitotic dysfunction in vitro and in vivo, suggesting that the requirement for ATRX in
normal cortical development and mitotic cell division might be linked. Binary control of
neuronal progenitor proliferation or differentiation is considered the primary mechanism
of mammalian cortical neurogenesis in the developing brain, and is thought to be
determined primarily by the regulation of asymmetric progenitor cell division. In chapter
four I report that apical neuronal progenitors of the Atrx-null forebrain display a
disruption in the balance of symmetric to asymmetric cell divisions, leading to an altered
complement of differentiated neurons in the postnatal cortex, providing a novel
requirement for ATRX in cortical development. Taken together, this data present a novel
role for the chromatin remodeling protein ATRX in mitotic cell division and cortical
neurogenesis.
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Chapter 1

1

Introduction
1.1

General Introduction

Mitotic cell division (Mitosis) is one of the most fundamental processes in the life cycle
of every eukaryotic cell. In essence, the objective of mitosis is to transmit a replicated
copy of the parental genome to two daughter cells. However, with the emergence of
multicellular organisms, with diverse tissues and organs, mitotic cell division is no longer
solely a process of genetic replication, but is a critical aspect of the global developmental
process. Progenitor cells can give rise to a variety of different cell types within a tissue, a
process that is often governed by asymmetric (or ‘unequal’) cell division (Horvitz and
Herskowitz, 1992).

Many studies have shown that asymmetric cell division in the

developing mammalian brain is critical for normal brain development, and it is believed
that disturbances in this process underlie some human intellectual disability disorders
[Reviewed in (Kaindl et al., 2009)].

Mutations in the ATRX gene cause a mental

retardation syndrome called alpha thalassemia mental retardation X-linked (ATR-X).
Studies in the mouse have confirmed a requirement for ATRX in normal brain
development, however the precise role of ATRX in neurodevelopment is largely
unknown, and is the topic of this thesis.

1.2
1.2.1

The ATRX Gene and Protein
The ATRX Gene Encodes a Member of the Snf2 Family of
Chromatin Remodeling Proteins

The human ATRX gene contains 36 exons spanning over 300 kilobases (kb) of genomic
DNA on the X chromosome (Xq13.3) (Gibbons et al., 1995b; Gibbons et al., 1995a;
Picketts et al., 1996). The gene produces two major protein isoforms, a full length 280
kilodalton (kDa) protein (ATRX) encoded by a 10.5 kb messenger RNA (mRNA)
(NM_000489.3), and a ~200 kDa truncated protein, ATRXt, encoded by a ~7 kb mRNA
transcript truncated at exon 11 by an alternative splicing event that retains this intron and
leads to the use of a proximal intronic poly(A) signal (Garrick et al., 2004). The mouse
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Atrx gene shows a similar genomic structure to its human homolog, and encodes a protein
(mATRX) of similar molecular weight with broad regions of high sequence conservation
(Picketts et al., 1998). Both major protein isoforms are highly conserved in human and
mouse, suggesting that each likely fulfill important biological functions in both
organisms (Garrick et al., 2004). Because of this homology the mouse has been used
extensively as a model to study many aspects of the Atrx gene and protein, particularly its
role in development. ATRX transcripts have been detected in all human and mouse
tissues examined to date, however the relative transcript abundance varies widely, as does
the ratio between the two major transcripts (Gecz et al., 1994; Garrick et al., 2004). An
examination of ATRX expression in various human tissues found that, in human fetal
tissues ATRX mRNA expression is highest in the brain, where the full-length transcript is
most abundant. In other fetal tissues where expression levels are lower, each transcript is
present in roughly equivalent amounts. In contrast, ATRX is poorly expressed in the adult
brain, but is most abundant in skeletal muscle, where again the full-length transcript
predominates (Garrick et al., 2004). These observations support the hypothesis that the
two major isoforms perform independent biological functions, and are subjected to
different regulatory mechanisms in a variety of tissues throughout development.
The full-length ATRX protein isoform contains two major conserved domains, (1) a
carboxyterminal (C-terminal) helicase/adenosine triphosphatase (ATPase) domain
belonging to the Sucrose non-fermenting 2 (Snf2) family of helicase-related chromatin
remodeling enzymes, and (2) an N-terminal [ATRX-DNMT3-DNMT3L (ADD)] domain
containing a plant homeodomain (PHD)-like zinc finger (Figure 1-1) (Picketts et al.,
1996). The major truncated isoform, ATRXt, retains the N-terminal ADD domain but
lacks the C-terminal Snf2 domain, likely conferring a unique biological function
distinguishing the two isoforms (Garrick et al., 2004). Sequence similarity between
ATRX and mATRX are highest within these 2 domains (>90%), suggesting conservation
of important functional properties between the two homologs (Picketts et al., 1998).

2

Figure 1-1. Schematic of the ATRX protein domain structure
The full length ATRX, and truncated ATRXt protein are depicted above. Major domains
are shown: the PHD zinc finger-like domain (ADD), Snf2 chromatin remodeling domain
(Helicase domain), the P box a (P), and glutamine-rich region (Q).

Below is a

representation of the amino acid similarity between the human and mouse proteins.
Reproduced with permission from: Gibbons et al. (2008) Human Mutation 29(6):796-802
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1.2.2

The ATRX Snf2 Domain

The Snf2 protein family belongs to the SF2 superfamily of ATP-hydrolysing DNA and
RNA helicases, which are characterized by a conserved stretch of seven short collinear
helicase motifs (I, Ia, II, III, IV, V, VI), and have been found in all eukaryotes
(Gorbalenya et al., 1988; Singleton et al., 2007). Structurally, this array of motifs is
organized into two recA-like domains with an active cleft between them, allowing the
transformation of chemical energy from ATP hydrolysis into mechanical motion
(Subramanya et al., 1996; Flaus et al., 2006). Members of the large Snf2 protein family
are generally believed to utilize the energy of ATP hydrolysis to act as the catalytic
molecular motor subunits of larger multi-protein complexes involved in many DNA and
chromatin-dependent processes (Knizewski et al., 2008).

Snf2 proteins have been

identified in many such complexes, including transcription-coupled repair (ERCC6
subfamily), nucleotide excision repair (RAD16), recombination repair (RAD54
subfamily), replication and gene-specific transcriptional activation (SNF2 subfamily),
transcriptional repression (MOT1), destabilization of reconstituted nucleosomes (SNF2
and SNF2L subfamilies) and chromosome segregation and mitotic recombination
(lodestar) [Reviewed in (Carlson and Laurent, 1994)]. Based on sequence alignment
data, ATRX has been classified within the Rad54-like subfamily of Snf2 proteins (Flaus
et al., 2006). Despite the presence of the conserved ‘helicase’-like motif, no member of
the Snf2 family has been shown to possess DNA or RNA helicase (unwinding of doublestranded nucleic acids) activity (Pazin et al., 1997). Rather, most Snf2 family members
exhibit ATP-dependent DNA translocation, and likely exert their biological effects
through the disruption of DNA-nucleosome interactions, known as chromatin
remodeling, as they translocate along a chromatin substrate, thereby altering the
accessibility of nucleosomal DNA to functionally specific auxiliary proteins like
transcription factors and DNA repair proteins [Reviewed in (Kingston et al., 1996;
Mohrmann and Verrijzer, 2005; Clapier and Cairns, 2009)].
Initial in vitro studies confirmed that the helicase domain of recombinant ATRX
(rATRX) does in fact possess ATPase activity at levels similar to other Snf2 proteins
(SNF2H, SNF2L) that was stimulated (2-fold) by the presence of mononucleosomes, but
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not by naked DNA (Tang et al., 2004). More recently it was shown that the ATPase
activity of rATRX can be stimulated by naked DNA (9-fold) and mononucleosomes (4fold), consistent with the known enzymatic properties of the Rad54 subfamily of Snf2
proteins to which ATRX belongs (Mitson et al., 2011), however the cause of the disparity
between the two studies is unknown. Many Snf2 proteins utilize ATP hydrolysis to fuel
DNA translocase activity (Lia et al., 2006; Amitani et al., 2006), which is classically
measured by the ability of the enzyme to displace a third strand of DNA wrapped around
a DNA double helix, known as a DNA triple helix (Saha et al., 2002; Jaskelioff et al.,
2003; Whitehouse et al., 2003; Dürr et al., 2005). Triple-helix displacement activity has
been confirmed for rATRX (Xue et al., 2003), and has been shown to depend upon intact
ATPase activity (Mitson et al., 2011), confirming that the Snf2 domain of ATRX acts as
an ATP-dependent DNA translocase consistent with its conserved sequence similarity to
the Snf2 protein family.

1.2.3

The ATRX ADD Domain

The N-terminal ADD domain of ATRX is a cysteine-rich region containing a PHD-like
zinc finger, a GATA-like zinc finger, and a flanking C2C2 α-helical motif, that assemble
into a large globular domain through extensive hydrophobic interactions (Argentaro et
al., 2007). This region is highly related to, and unique to, the DNA methyltransferase 3
(DNMT3) family of de-novo DNA methyltransferases (DNMT3A, DNMT3B, and
DNMT3L) (Xie et al., 1999; Aapola et al., 2000; Argentaro et al., 2007). Zinc fingers are
common in chromatin-associated proteins and generally act to mediate protein-protein
interactions that are thought to function primarily as tethers to chromatin via interactions
with exposed histone tails (Bienz, 2006).

Not surprisingly, the ADD domain of

DNMT3A and DNMT3L interact with unmodified histone H3 tails (Ooi et al., 2007;
Otani et al., 2009), and ATRX has been found to associate with chromatin through
specific histone modifications. The ADD domain of ATRX can bind to histone H3 tails
that are trimethylated at lysine 9 (H3K9me3) and unmethylated at lysine 4 (H3K4me0)
(Dhayalan et al., 2011), and has recently been proposed to interact with the lysine 4
residue of the histone variant H3.3 in mouse embryonic stem (ES) cells (Wong et al.,
2010).
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Functionality of PHD domains depends on the coordinated binding of zinc ions within a
conserved hydrophobic core that stabilizes protein folding (Frankel et al., 1987; Shi and
Berg, 1995). Although not identical in sequence to known PHD and GATA zinc fingers,
the structure of the ATRX-ADD domain has been solved and shown to bind zinc ions in a
configuration highly similar to those reported for GATA-1 and PHD fingers (Argentaro
et al., 2007). The zinc finger of GATA-1 is able to bind directly to target DNA elements,
and the domain structure of the ATRX-ADD domain suggests a similar basic patch on αhelix 1 may be used for DNA binding (Argentaro et al., 2007), supported by the
observation that the ATRX-ADD domain can bind DNA homopolymers in vitro
(Cardoso et al., 2000).
Interestingly, the Snf2 and ADD domains are separated by a large unstructured stretch of
~1300 amino acid residues.

It has been speculated that this placement of a long,

potentially flexible, linker region between these two domains is a functionally important
feature of the structure of ATRX (Mitson et al., 2011), as this region is also conserved in
chicken and frog.

1.2.4

ATRX Function

In mammalian cells, ATRX is a nuclear protein and >50% of total ATRX is tightly
associated with DNA and/or chromatin, consistent with the presence of the conserved
domains in ATRX that are commonly found in chromatin associated proteins (McDowell
et al., 1999). ATRX is enriched primarily at pericentromeric heterochromatin (PCH), and
at promyelocytic nuclear bodies (PML-NBs), and has more recently been localized to
telomeric chromatin, and some euchromatic sites. It is believed that ATRX functions
primarily as a regulator of gene transcription and of condensed heterochromatin through
distinct mechanisms, including direct DNA binding, regulation of genomic imprinting,
and deposition of specific histone subunits at a variety of genomic regions.

1.2.5

ATRX Interacts With the Death-Domain Associated Protein
DAXX

Because SWI/SNF family proteins are typically found in large nuclear chromatin
remodeling complexes, early studies focused on characterizing the potential binding
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partners of ATRX, and the nature of the potential complexes to which it belonged. Coimmunoprecipitations (Co-IPs) from human and mouse cells identified a specific
interaction between ATRX and the death domain associated protein DAXX (Xue et al.,
2003; Tang et al., 2004; Ishov et al., 2004). DAXX is a multifunctional protein found
primarily in the nucleus where it localizes to PML-NBs (Ishov et al., 1999; Everett et al.,
1999; Torii et al., 1999) and condensed chromatin (Ishov et al., 1999) and interacts with
multiple transcription factors, including Pax3, Pax5 and ETS1, and other chromatin
associated proteins DNA methyltransferase 1, histone deacetylases, and core histones
(Hollenbach et al., 1999; Li et al., 2000; Hollenbach et al., 2002; Lin et al., 2003a).
Because of this, DAXX is believed to function primarily as a transcriptional regulator.
Peptide studies revealed that most of the total full length ATRX pool is associated in near
equimolar amounts with DAXX in human nuclear extracts (Xue et al., 2003), suggesting
that ATRX function might depend primarily on this association. These early studies
found that the ATRX-DAXX complex possesses ATP-dependent chromatin remodeling
activity, suggesting that together these proteins might influence a range of DNAdependent processes through the modulation of chromatin structure (Xue et al., 2003;
Tang et al., 2004).

1.2.6

The ATRX/DAXX Complex Localizes to PML-NBs and
Constitutive Heterochromatin

In both human and mouse cells, ATRX is primarily enriched at PCH throughout the cell
cycle (McDowell et al., 1999).

Pericentromeric heterochromatin is a constitutively

condensed region of heterochromatin flanking the centromeres of eukaryotic
chromosomes, and is essential for the normal organization and function of the
centromere, kinetochore assembly, and mitotic cell division [reviewed in (Pidoux and
Allshire, 2005)]. Distinct mechanisms appear to recruit ATRX to PCH in mammalian
cells. The methyl-CpG binding protein 2 (MeCP2) and ATRX interact in vitro, and
MeCP2 is required for the proper colocalization of ATRX to PCH in cortical neurons
from the adult mouse brain (Nan et al., 2007).

ATRX also interacts with the

heterochromatin binding protein 1 (HP1) family of proteins (Le Douarin et al., 1996;
McDowell et al., 1999; Bérubé et al., 2000), and HP1α has been shown to recruit ATRX
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to PCH in mESCs (Kourmouli et al., 2005). HP1 proteins are an integral component of
condensed chromatin at pericentric regions, and loss of HP1, or the yeast homolog Swi6,
leads to loss of heterochromatin, centromeric instability and mitotic defects (Ekwall et
al., 1995; Amor et al., 2004). A growing number of chromatin remodeling enzymes have
been found to maintain the structural integrity of PCH, with deficiencies leading to
mitotic abnormalities (Lejeune et al., 2007; Bourgo et al., 2009). Interestingly, depletion
of ATRX in mouse oocytes leads to mitotic spindle and chromosome segregation defects,
and centromere dysfunction, including centromere fusions, and centromere containing
micronuclei (De La Fuente et al., 2004; Baumann et al., 2010) DAXX colocalizes to PCH
with ATRX during S-phase in mouse embryonic fibroblasts (MEFs) (Ishov et al., 2004;
Drané et al., 2010), and ATRX is required to recruit DAXX to PCH in mouse oocytes
(Baumann et al., 2010). Interestingly, Daxx knockout MEFs are prone to forming binucleated cells, suggesting a defect in cell division in these cells (Ishov et al., 2004).
Within the nucleus, ATRX also co-localizes with DAXX at PML-NBs in human and
mouse cells (Xue et al., 2003; Ishov et al., 2004), and the recruitment of ATRX to these
sites is mediated by DAXX. PML-NBs are large nuclear protein complexes implicated in
nearly every cellular process, making functional classification difficult (Quimby et al.,
2006; Shen et al., 2006). It is generally believed that PML-NBs serve two primary
functions, (1) as protein depots that sequester abnormal proteins related to pathological
conditions, and (2) to act as catalytic surfaces where proteins accumulate to be posttranslationally modified (Bernardi and Pandolfi, 2007).

More recently it has been

proposed that PML-NBs could in fact be active sites for such nuclear functions as
transcriptional regulation and chromatin remodeling (Lallemand-Breitenbach and de Thé,
2010).

1.2.7

ATRX and DAXX Deposit H3.3 at Specific Genomic Regions

Recently several independent studies have identified a novel role for the ATRX-DAXX
complex in the incorporation of the histone variant H3.3 at specific genomic regions,
including telomeres and pericentric heterochromatin (Goldberg et al., 2010; Wong et al.,
2010; Drané et al., 2010; Lewis et al., 2010).
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Histones can regulate chromatin function through the use of covalent post-translational
modification (phosphorylation, methylation, acetylation, ubiquitylation) of amino acid
residues on their tail domains, and by the use of non-allelic histone variants [Reviewed in
(Kamakaka and Biggins, 2005)]. In mammals, the histone variant H3.3 varies from the
canonical H3 (H3.1) at only 5 amino acids, which give H3.3 unique properties, such as
targeting to specific chromatin domains. Unlike H3.1, H3.3 can be incorporated into
chromatin outside of S-phase, and is typically associated with sites of active DNA
transcription.

These differences likely reflect the interactions of the histones with

different assembly factors, termed histone chaperones. In human cells, H3.1 is found
mainly in a complex with the DNA replication dependent chaperone Chromatin
Assembly Factor 1 (CAF-1) while H3.3 is found with the DNA replication independent
chaperones HIRA or CHD1 (Tagami et al., 2004; Konev et al., 2007).
Surprisingly, ATRX and DAXX were recently identified in purified histone H3.3, but not
H3.1 preassembly complexes from HeLa cells (Drané et al., 2010; Lewis et al., 2010). A
purified complex of ATRX-DAXX can assemble and mobilize H3.3/H4 containing
nucleosomes on a DNA template in vitro, indicating that this heterodimer possesses
chromatin remodeling activity specific to H3.3-nucleosomes (Lewis et al., 2010).
Depletion of ATRX or DAXX in mouse embryonic fibroblasts (MEFs) using RNAi
reduced the amount of H3.3 deposition at pericentromeric heterochromatin, resulting in a
downregulation of pericentric repeat transcripts in these cells (Drané et al., 2010). It has
recently been shown that pericentric repeats are highly transcribed in mammalian cells,
and paradoxically in yeast these transcripts are required for the RNAi mediated
heterochromatinization of PCH (Grewal and Elgin, 2007), and disruption of this pathway
in yeast leads to loss of PCH and centromeric dysfunction leading to mitotic defects
(Verdel and Moazed, 2005).
In addition, ATRX is also enriched at telomeric chromatin in pluripotent mouse ES cells
(ESCs) during interphase, when telomeric DNA is undergoing replication and processing
(Wong et al., 2010). In Atrx-null ESCs, H3.3 is depleted from telomeric regions, and
there is an upregulation of telomere specific transcripts (Telomeric repeat containing
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RNA, TERRA) in these cells, suggesting loss of a repressive/silent heterochromatic
environment (Goldberg et al., 2010). PHD fingers have a marked preference for binding
histone H3 lysine 4 (H3K4), and the interaction between ATRX and H3.3 is lost when
the K4 residue of H3.3 is mutated, which also prevents the telomeric localization of
ATRX (Wong et al., 2010). In contrast, ATRX is not found in the H3.3 complex in
DAXX-/- MEFs, indicating that DAXX is also required for the association of ATRX with
H3.3 (Lewis et al., 2010).

1.2.8

Mutations in the ATRX Gene Cause X-linked Mental
Retardation

The human ATRX gene (MIM# 300032) was first described in 1995. Mutations in this
gene cause ATR-X syndrome (Alpha-Thalassemia mental Retardation, X-linked)
syndrome (MIM# 301040), a severe form of X-linked mental retardation (XLMR) that
occurs almost exclusively in males (Gibbons et al., 1992; Gibbons et al., 1995b; Gibbons
et al., 1995a). Signs of ATR-X syndrome are evident at birth, and constitute a broad but
remarkably uniform phenotypic spectrum affecting many bodily organs, most notably the
central nervous system.

Typically, patients show global developmental delay with

moderate to profound learning difficulties associated with severe expressive language
disorder, severe to profound mental retardation (95% of cases), and facial dysmorphology
(94%). Affected individuals also show postnatal microcephaly (reduced brain and skull
size developing after birth, 75%), genital abnormalities (80%), skeletal abnormalities
(90%), short statue (65%), seizures (30%), cardiac defects (20%), and renal/urinary
abnormalities (15%).

One of the characteristic manifestations, commonly used for

clinical diagnosis, is a type of anemia called α-thalassemia (86%), caused by the
reduction of α-globin gene expression in peripheral red blood cells [summarized in
(Gibbons, 2006)]. This α-globin deficiency leads to the consequent aggregation of βglobin peptides into tetrameric β4 (Haemoglobin H, or HbH), a non-functional form of
haemoglobin with very high oxygen affinity and impaired ability to supply oxygen to
tissues (Higgs and Weatherall, 2009).
Mutations in ATRX have also been identified in a number of other XLMRs with a range
of overlapping symptoms, including Juberg-Marsidi (Villard et al., 1996), X-linked
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mental retardation with spastic paraplegia (Lossi et al., 1999), Carpenter-Waziri (Abidi et
al., 1999), Holmes-Gang (Stevenson et al., 2000), Smith-Fineman-Myers (Villard et al.,
2000) and Chudley-Lowry (Abidi et al., 2005) syndromes.
To date over 200 ATR-X cases from 182 families have been identified, carrying a total of
113 different ATRX mutations. Despite the steadily growing cohort, no population-based
studies have yet been conducted to establish the prevalence of this condition, and the
proportion of XLMRs attributable to ATRX mutations is currently unknown, but is
currently estimated at around 1/1,000,000 (Gibbons et al., 2008).

1.2.9

ATRX Disease Mutations Affect Protein Stability and
Function

Some pathogenic ATRX mutations have been studied biochemically, and all have been
found to impair protein function, or reduce steady state protein levels, likely contributing
to the disease etiology through protein dysfunction or insufficiency. Nearly all nontruncating ATR-X disease-causing mutations in ATRX lie within the conserved ADD
(49%) or Snf2 (30%) domains, suggesting their importance for the normal function of
ATRX during development (Figure 1-1) (Gibbons et al., 2008). These two regions are
separated by a structurally disordered stretch of over 1300 amino acid residues that lack
any known pathological mutations. Two theories have been proposed to explain this, (1)
it is believed that mutations here may result in neutral polymorphisms, and thus are not
detected because they do not result in protein dysfunction or pathology, or (2) mutations
here are severely detrimental to normal protein function and act as non-viable nullalleles.
A number of mutations found in the Snf2 domain show impaired DNA stimulated
ATPase and DNA translocase activity.

Other mutations result in uncoupled DNA

binding and ATPase activity, resulting in abnormally high levels of ATPase activity even
in the absence of stimulation by DNA, and reduced DNA translocase activity (Mitson et
al., 2011). The precise effect of these mutations on ATRX function is unclear, though
due to their position within the folded peptide, they are speculated to directly affect ATP
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hydrolysis, DNA binding, or the communication of a DNA binding event to the catalytic
site.
Structure/function analysis has found that many missense mutations in the ADD domain
associated with ATR-X syndrome affect buried residues that are important for protein
structural integrity and stability (Argentaro et al., 2007). However other mutations that
map to the surface-exposed zinc-binding cysteine residues, or protein binding helical
regions, are predicted to directly interfere with DNA or protein interactions (Argentaro et
al., 2007). Indeed, some patient mutations in the ADD domain have been found to impair
the DNA (Cardoso et al., 2000) or protein (Dhayalan et al., 2011) binding activity of
ATRX. Interestingly, mutations in the ADD domain are associated with more severe
psychomotor retardation than those found in the Snf2 helicase domain for unknown
reasons.
Almost all female carriers of pathogenic ATRX mutations show no disease symptoms,
however approximately 1 in 4 have signs of mild alpha thalassemia (Gibbons et al.,
1992). Most carriers have drastically skewed pattern of X chromosome inactivation with
the disease bearing X being preferentially inactivated, preventing pathogenesis. Some
exceptions to this paradigm have been documented. Two cases of balanced (random) X
inactivation have been documented, one of which presented with mild MR (Wada et al.,
2005), however an association with the ATRX mutation was not clear. In a unique case, a
girl heterozygous for an ATRX mutation showed preferential silencing of the wild type X
chromosome and presented with characteristics of ATR-X syndrome (Badens et al.,
2006).
No known ATRX null alleles have been identified, and all clinical mutations assayed to
date, including nonsense mutations, retain some basal expression levels of full-length
ATRX protein and are thought to primarily disrupt protein function by destabilization or
protein mislocalization resulting in hypomorphic alleles (Argentaro et al., 2007; Gibbons
et al., 2008; Mitson et al., 2011). The mechanism leading to production of full-length
protein from an allele carrying a truncating mutation remains unclear, though it has been
speculated that mutational skipping via alternative splicing may be predominantly used to

12

preserve some full-length protein expression. ATRX dosage also appears to be critical
for normal protein function, since all studied disease cases show significantly reduced
protein levels (3-55% of normal levels), despite some retaining apparently normal protein
function, demonstrated by normal ATPase activity (Argentaro et al., 2007; Mitson et al.,
2011). Interestingly, loss of full length ATRX beginning at the morula stage of
development results in embryonic lethality by E9.5, likely due to defects in the
extraembryonic trophoblast (Garrick et al., 2006), and may explain why no null alleles
are observed in humans. Furthermore, depletion of ATRX in the mouse oocyte leads to
meiotic abnormalities and aneuploidy in fertilized 1-cell zygotes, and severely reduced
fertility (Baumann et al., 2010), suggesting that genomic instability may also contribute
to embryonic lethality.
Taken together, the collection of disease causing mutations, and their effects on protein
function and stability suggest a critical role of ATRX in development, specifically related
to the integrity of the conserved Snf2 and ADD domains.

1.2.10

Loss of DNA Methylation at Repetitive Sequences in ATR-X
Patients

In human cells, immunofluorescence staining revealed that ATRX is enriched on the
short arms of acrocentric chromosomes where the GC-rich ribosomal DNA (rDNA)
arrays are found (McDowell et al., 1999). More recently ATRX was localized to rDNA
sequences in human erythroblasts using ChIP (Law et al., 2010). The rDNA genes
encode the ribosomal RNAs (rRNA), essential components of the ribosome, and their
highly regulated expression is required to meet the demand for protein synthesis in
growing cells.

Expression of rRNA is regulated by complex patterns of DNA

methylation within the promoters and coding sequences, however in general DNA
methylation at rDNA genes is associated with transcriptional silencing (Bird et al., 1981).
In peripheral blood cells from normal individuals, approximately 20% of the transcribed
rDNA units are methylated within Cytosine-Guanine dinucleotide (CpG) rich regions,
likely corresponding to silenced rDNA genes. Surprisingly, in ATR-X patients, most
rDNA genes have lost genomic methylation at CpG rich regions, corresponding to the
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transcribed 28S, 18S, and 5.8S rDNA genes (Gibbons et al., 2000). A similar loss of
rDNA methylation was also observed in mouse ES cells lacking Atrx expression (Atrxnull
ES cells) (Garrick et al., 2006), and ATRX deficient mouse brain (Kernohan et al., 2010).
The effect of this hypomethylation on rRNA transcription has not yet been assessed, and
any relationship to disease pathology is unknown. Furthermore, other repetitive elements
from ATR-X patients show disturbed DNA methylation, including a Y chromosome
specific repeat element (DYZ2), a subtelomeric/centromeric repeat (TelBam3.4), and loss
of pericentromeric DNA methylation (Nan et al., 2007) indicating that ATRX influences
DNA methylation at specific regions (Gibbons et al., 2000).

1.2.11

ATRX Regulates Gene Expression

The first evidence that that ATRX regulates the expression of particular genes was the
observation that ATR-X patient erythrocytes were severely depleted of α-globin
transcripts (leading to α-thalassaemia), despite the presence of a normal α-globin locus,
and normal expression from the highly related β-globin locus (Wilkie et al., 1990). The
α- and β- globin genes, although related, are found within very distinct genomic
environments.

The α-globin cluster is found in a GC (Guanine-Cytosine) rich

subtelomeric region with a high density of CpG islands and G-rich tandem repeats,
suggesting that ATRX might regulate gene expression by targeting specific chromatin
environments. Recently it was shown that ATRX is enriched at many GC rich regions of
the human and mouse genome, including G-rich telomeric (TTAGGG)n repeats,
subtelomeric TAR1 repeats, and CpG islands (Law et al., 2010). Interestingly, many of
these elements are associated with variable nucleotide tandem repeat elements (VNTRs),
and are predicted to adopt unusual G-quadruplex (G4) structures under physiological
conditions (Lipps and Rhodes, 2009). These non-β G4 DNA conformations are likely to
form once the DNA becomes single stranded, such as during DNA replication or
transcription, and may consequently interfere with these processes through stochastic
inhibition. It was recently shown that ATRX can bind G4 DNA structures in vitro, and it
has been proposed that under physiological conditions ATRX may associate with, and
resolve these structures in different genomic contexts to facilitate gene transcription,
DNA replication, and DNA repair (Law et al., 2010). Indeed it is now known that the α-
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globin cluster is associated with a VNTR, and that the α-globin downregulation observed
in ATR-X patients is proportional to the size of the VNTR associated with the α-globin
locus (Law et al., 2010), providing a possible mechanism explaining the variable degrees
of α-thalassaemia seen in individuals with identical ATRX mutations.
To further examine the role of ATRX in transcriptional regulation of gene expression,
microarray studies on ATRX-deficient mouse brain tissue revealed that a number of
imprinted genes are upregulated in the absence of ATRX, including the H19 gene (Levy
et al., 2008; Kernohan et al., 2010). Imprinted genes are expressed from parental-specific
(maternal/paternal) alleles, determined by the differential methylation of regulatory
elements (DMRs). The H19/Igf2 imprinted domain contains several DMRs, including
one 2 kb upstream of H19 that acts as an imprinting control region (ICR). The H19 ICR
is methylated on the silent paternal allele in many tissues, including the brain (FergusonSmith et al., 1993; Bartolomei et al., 1993). It was found that ATRX binds to the
maternal H19 ICR and is required to recruit the proteins MeCP2 and cohesin to this site
(Kernohan et al., 2010). Interestingly DNA methylation at the maternal H19/Igf2 ICR
was unchanged in the ATRX-deficient cells, but there was increased acetylation of
histone H3 and H4 (H3Ac and H4Ac), markers of open chromatin, indicating that ATRX
is required for normal epigenetic regulation of specific imprinted loci. Therefor, ATRX
can function as a transcriptional regulator of a subset of genes.

1.2.12

ATRX Dosage is Critical for Normal Development of the
Mouse Brain

The study of ATRX function in mammalian development has relied exclusively on the
mouse model system.

To date, conventional zygotic-null Atrx mice have proven

impossible to obtain, hindering traditional reverse genetic approaches to study global
protein function. To circumvent this limitation, conditional models of Atrx inactivation
have been developed that rely on the Cre recombinase-loxP (Cre-lox) mediated DNA
recombination system to induce tissue- and stage-specific Atrx null alleles (Bérubé et al.,
2005; Garrick et al., 2006; Ritchie et al., 2008; Seah et al., 2008; Levy et al., 2008;
Medina et al., 2009; Solomon et al., 2009). The Cre recombinase enzyme is a type I
topoisomerase from P1 bacteriophage that catalyzes site-specific DNA recombination,
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and has been used extensively in the field of molecular genetics as a tool to modify
chromosomal DNA sequences. The enzyme acts on the 34 bp loxP DNA sequence,
irreversibly fusing two loxP sites together while excising the intervening DNA.
To apply the Cre-lox system in the study of Atrx function during development, an Atrx
allele with loxP sites flanking exon 18 (AtrxloxP) has been generated, and a mouse line has
been established using targeted recombination that carries this allele at the endogenous
Atrx locus (as either heterozygous or homozygous) without any deleterious effects
(Bérubé et al., 2005). These AtrxloxP female mice can be mated with male mice carrying
the Cre recombinase gene to produce offspring carrying both the AtrxloxP and Cre alleles.
The expression of Cre in the presence of the AtrxloxP allele leads to the recombination of
the loxP sites flanking Atrx exon 18 and results in the loss of full length ATRX
expression via mRNA truncation and destabilization, yielding no detectable full-length
protein, while retaining normal ATRXt expression (Bérubé et al., 2005). Selectivity of
the Cre mediated inactivation of ATRX has been achieved by using tissue- or stagespecific promoters to drive Cre expression, either by transgenesis of a full expression
cassette or targeted knock-in of the Cre coding sequence (CDS) at a specific gene locus
(Bérubé et al., 2005; Garrick et al., 2006; Ritchie et al., 2008; Seah et al., 2008; Levy et
al., 2008; Medina et al., 2009; Solomon et al., 2009). Using this system, a model of
conditional Atrx inactivation beginning at the 8-16 cell stage was found to be lethal
during embryogenesis due to failure of extraembryonic trophoblast formation (Garrick et
al., 2006), indicating a fundamental requirement for ATRX during early placental
development.
Since inherited ATRX mutations lead to diseases affecting the central nervous system,
most molecular genetic approaches have focused on disrupting Atrx expression in the
developing mouse brain using brain-specific gene promoters from the forkhead box G1
(Foxg1) and Nestin genes to drive Cre expression (Bérubé et al., 2005; Ritchie et al.,
2008; Seah et al., 2008; Levy et al., 2008; Kernohan et al., 2010). In one extensively
used model, a targeted knock-in allele of the Cre CDS at the FoxG1 (Foxg1Cre) locus
results in the expression of Cre between E8/E9 wherever Foxg1 is usually expressed,
including in the telencephalic neuroepithelium, basal ganglia, olfactory bulbs, and nasal
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epithelium (Hébert and McConnell, 2000).

When male mice heterozygous for the

Foxg1Cre allele (Foxg1Cre/+) are crossed with female mice carrying AtrxloxP, the
inheritance of both alleles in offspring (AtrxFoxg1Cre mice) results in the elimination of full
length Atrx expression in the tissues where Cre recombinase is expressed, and all tissues
derived from them (Bérubé et al., 2005).

Importantly, this model eliminates Atrx

expression in the progenitor cell population of the developing forebrain (the neuronal
progenitors of the telencephalic neuroepithelium) prior to the onset of neurogenesis,
resulting in the complete loss of Atrx expression in nearly all of the cells of the ensuing
forebrain.

The postnatal AtrxFoxg1Cre (also referred to as Atrx-null) forebrain is

characterized by increased levels of neuronal apoptosis, cortical hypocellularity, and
decreased cortical and hippocampal volume at birth (Bérubé et al., 2005). Interestingly,
rescue of neuronal cell death using a p53-null background only partially rescues cortical
size in the Atrx-null mouse, suggesting that additional mechanisms contribute to the
hypocellular Atrx-null brain outside of strict cell survival (Seah et al., 2008).
Furthermore, this model also leads to a reduced birth weight and perinatal lethality in
AtrxFoxg1Cre offspring, suggesting that Atrx expression in the developing brain is important
for normal growth and viability.
Another model of Cre mediated Atrx inactivation in the developing brain has been
characterized that utilizes Cre expression from a randomly integrated Nestin-Cre
transgene (AtrxNestinCre mice) (Bérubé et al., 2005). Nestin expression is specific to the
neuronal progenitors of the developing forebrain, similar to Foxg1, but expression is
detected later, resulting in preserved ATRX expression only in the early-born neurons of
the marginal zone and subplate of the cortical plate (Bérubé et al., 2005). The cortex of
AtrxNestinCre mice is hypocellular, however to a lesser extent than AtrxFoxg1Cre mice,
possibly due to the delayed temporal inactivation of the Atrx gene and the retained ATRX
expression in a subset of neurons (Bérubé et al., 2005).
To further investigate the role of Atrx in neurodevelopment, a transgenic mouse model of
Atrx overexpression has also been characterized (Bérubé et al., 2002).

Global

overexpression of human ATRX cDNA under the control of a CMV enhancer/chicken βactin promoter shows growth retardation, neural tube defects, and high incidence of
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embryonic death. The embryonic forebrain displays a thickening and disorganization of
the neuroepithelium and increased cellularity. Mice that survive into the postnatal period
display high rates of perinatal death, seizures, craniofacial defects, and abnormal
behaviour (Bérubé et al., 2002).
Taken together, these findings indicate that ATRX dosage is essential for normal neuronal
proliferation and neuron survival, and is a critical determinant of cortical size, however,
the mechanisms linking ATRX deficiency with abnormal neurodevelopment remain
largely unknown.

1.3

Mitotic Cell Division

Mitotic cell division (Mitosis) is the process whereby a eukaryotic cell separates its
replicated genome, and other cell constituents, into two genetically identical daughter
cells. The primary result of mitosis is the propagation and multiplication of a complete
genome into a new generation of cells, however in multicellular organisms mitosis also
generates the diverse cell types produced during development, and is required for tissue
homeostasis in adult organisms, including mammals. Disruption of mitotic cell division
can lead to many diseases in humans, including cancer and mental retardation [reviewed
in (Thompson et al., 2010) and (Woods et al., 2005)].

1.3.1

The Cell Cycle: Overview

In actively dividing cells, the cell cycle is divided into two major phases, Interphase and
the Mitotic (M) phase. Interphase consists of three distinct phases, Gap 1 (G1), Synthesis
(S), and Gap 2 (G2), while M-phase consists of both mitosis and cytokinesis. The longest
stage of the cell cycle is G1, while the cell undergoes protein and organelle synthesis and
growth. Prior to the onset of mitosis, the cellular genome is replicated entirely during S
phase of the cell cycle, followed by a second period of growth and protein synthesis
during G2 in preparation for cell division.

1.3.2

The Stages of Mitosis

Mitosis is categorized into a sequence of specific phases (Prophase, Prometaphase,
Metaphase, Anaphase, and Telophase), each characterized by specific events that occur
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within the cell at the microscopic level. Mitotic initiation and progression are tightly
regulated by a number of signaling pathways and checkpoints that act to ensure accurate
transmission of the cellular genome to the daughter cells, including the G2/M DNA
damage checkpoint and spindle assembly checkpoint (SAC).
During prophase, the nuclear envelope is disassembled and the chromatin fibers spread
throughout the nucleus are condensed into compacted mitotic chromosomes. Nuclear
envelope breakdown (NEBD) allows access of cytosolic factors, including the mitotic
spindle and chromosome condensing proteins (the condensin protein complex), to the
nuclear chromatin. As prophase proceeds, the mitotic spindle begins to form at the
centrosomes and the microtubule fibers elongate in search of the proteinaceous
kinetochores assembled on the chromosomal centromeres. Once the mitotic spindle has
captured a kinetochore from each sister chromatid, the replicated chromosome begins to
move towards the cell equator (or midzone) in preparation for segregation. The process
of moving the scattered chromosomes to the midzone is called chromosomes
congression. The replicated chromosomes are aligned at the midzone in a bi-orientation,
with each kinetochore bound by microtubules from opposing spindle poles. At this point
the spindle assembly checkpoint (SAC) prevents sister chromatid separation and
segregation by monitoring the kinetochore attachment to spindle microtubules. Once the
SAC is satisfied, the protein complex (cohesin) that prevents sister chromatid dissociation
is removed, allowing the segregation of one of each sister chromatid towards the
opposing spindle poles during anaphase. The polar movement of the sister chromatids is
facilitated by the shortening of the spindle microtubules. In addition, microtubules from
opposing poles push apart through forces exerted by the motor protein kinesin, and
cortical microtubules pull towards each pole through a dynein mediated force. During
telophase the chromosomes decondense due to the removal of chromatin bound
condensin proteins, and the nuclear lamina reforms around each new diploid complement
of chromosomes. The new nuclei, as well as cytosolic components and the plasma
membrane are terminally partitioned by a membrane fusion event during cytokinesis, the
final stage of M-phase (discussed below).
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1.3.3

Centromere Structure and Function

The centromere is the site of kinetochore assembly during mitosis, and is an essential
locus on each chromosome that is required for accurate division of genetic material
(Pidoux and Allshire, 2000). The kinetochore is a highly proteinaceous structure that
interacts with the microtubule fibers of the mitotic spindle, allowing the mechanical
motion of the chromosomes during mitosis.

Dysfunction of the centromere or

kinetochore can cause chromosome missegregation that can lead to aneuploidy or
polyploidy, typically rendering the cell inviable or possibly leading to tumorigenesis
(Weaver and Cleveland, 2005).
The centromeres of higher eukaryotes form on long stretches of repetitive DNA
sequences that typically span many hundreds to many thousands of kilobases (kb) (Gieni
et al., 2008). Primate centromeres are comprised of arrays of repetitive alpha satellite
DNA, a repeating unit of 171 base pairs (bp), which occur in higher order repeat units of
2-16 alpha-satellite monomers arranged in tandem to form arrays ranging from 200-5,000
kb (Schueler et al., 2001). In the mouse, Mus musculus domesticus, centromeric DNA is
composed of two distinct repetitive DNA sequences, the minor satellite DNA that is
found in the centromere and the major satellite DNA, which is located pericentrically
(Choo, 1997). Minor satellite units are 120 bp long and span ~600 kb of genomic DNA,
while the major satellite units are 234 bp long and span ~6 megabases (mb). Primate
alpha satellite repeat monomers show DNA sequence variation of up to 60% around a
common consensus sequence throughout the entire genome, and centromeric DNA
sequences between species are highly divergent, suggesting that DNA sequence alone
may not specify centromere function (Henikoff et al., 2001).

Although the DNA

sequences of eukaryotic centromeres vary widely, they are all commonly enriched with
nucleosomes containing the histone 3 variant centromeric protein A (CENP-A)
(Earnshaw and Migeon, 1985; Palmer et al., 1991; Meluh et al., 1998; Henikoff et al.,
2000; Sullivan, 2001; Oegema et al., 2001). The assembly of a functional kinetochore
depends on the centromeric enrichment of CENP-A containing nucleosomes, highlighting
the importance of chromatin composition in centromere specification. However, CENPA alone is not sufficient for centromere specification and kinetochore assembly (Van
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Hooser et al., 2001). Because of this, it is now believed that epigenetic mechanisms may
in fact be the primary means of centromere specification rather than DNA sequence.

1.3.4

Pericentromeric Heterochromatin and Chromatid Cohesion

The centromere is flanked on each side by constitutively condensed regions of chromatin
known as pericentromeric heterochromatin (Sullivan, 2001).

Rather than being

nonfunctional blocks of silent condensed chromatin, these regions are in fact essential for
centromere specification and contribute to sister chromatid cohesion and condensation
during mitosis (Hendzel et al., 1997; Bernard et al., 2001). Pericentromeric regions are
enriched with specific repressive epigenetic marks, including methylation of histone H3
at lysine 9 (H3K9me2 and H3K9me3) and histone H4 at lysine 20 (H4K20me3), and
enrichment of heterochromatic factors including Heterochromatin Protein 1 (HP1, the
homolog of yeast Swi6). Recruitment of HP1 to pericentromeric chromatin depends on
the interaction of its chromodomain with the H3K9me3 modification, which is catalyzed
by the histone methyltransferase enzyme Suv39h1 (Lachner et al., 2001). In turn, HP1
recruits the DNA methyltransferase 3b (DNMT3b), which methylates the cytosine (C)
residues of cytosine-guanine (G) dinucleotides (CpG), leading to silencing and
heterochromatinzation of pericentromeric DNA. These marks serve to maintain the
condensed structure of the pericentric chromatin and maintain chromatid cohesion
through recruitment of the cohesin protein complex (Nonaka et al., 2002; Amor et al.,
2004). HP1 proteins are an integral component of condensed chromatin at pericentric
regions, and loss of HP1 or Swi6 leads to loss of heterochromatin, centromeric instability
and mitotic defects (Ekwall et al., 1996; Amor et al., 2004). Interestingly, HP1α has been
shown to recruit ATRX to PCH in mESCs (Kourmouli et al., 2005), suggesting a specific
function for ATRX at this genomic locus. Supporting this hypothesis, a growing number
of chromatin remodeling enzymes have been found to maintain the structural integrity of
PCH, with deficiencies leading to mitotic abnormalities (Lejeune et al., 2007; Bourgo et
al., 2009).
Chromatid cohesion is achieved through the recruitment of the ring-shaped cohesin
complex, a protein tetramer that is thought to function by topologically encircling sister
chromatids, preventing their dissociation during the early stages of mitosis (Hirano, 2005;
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Nasmyth, 2005). The cohesin complex contains four core subunits: two subunits of the
structural maintenance of chromosomes (SMC) protein family, Smc1 and Smc3, the
kleisin family protein Rad21 and the accessory subunit SA1.

At pericentromeric

heterochromatin, HP1 recruits the cohesin subunit Rad21. Loss of HP1, and thus PCH
integrity, results in abnormal chromosome segregation during mitosis (Taddei et al.,
2001), premature loss of sister chromatid cohesion, and aneuploidy (Inoue et al., 2008).
Therefore, the proper association of cohesin with pericentromeric regions is essential for
normal mitotic cell division.
Recently it was discovered that RNA is an essential component of constitutive
pericentromeric heterochromatin (Maison et al., 2002; Muchardt et al., 2002). In the
fission yeast S. pombe, small double stranded RNA (dsRNA) generated by an RNAidependent mechanism is involved in the establishment and maintenance of
heterochromatic regions (Reinhart and Bartel, 2002; Volpe et al., 2002; Grewal and
Moazed, 2003; Ekwall, 2004; Schramke and Allshire, 2004). Surprisingly, these small
dsRNAs are encoded by the repetitive pericentromeric regions that were previously
thought to have been transcriptionally silent (Grewal and Elgin, 2007). Mutants for
components of the RNAi machinery, Argonaute (Ago1), Dicer (Dcr1) and RNAdependent RNA polymerase (Rdp1) show loss of pericentric heterochromatin and gene
silencing, loss of H3K9me3 and hpSwi6hp1 (the S. pombe homolog of mammalian HP1)
enrichment and mitotic defects (Volpe et al., 2002; Provost et al., 2002; Hall et al., 2003).
Because spSwi6hp1 contains a chromodomain with RNA binding properties, it is believed
that the siRNAs produced by Dicer are used to target Swi6 to pericentric regions to
promote heterochromatinization.

Transcripts have now been detected from

pericentromeric sequences throughout different stages of mammalian development,
during cellular differentiation, proliferation, senescence, and adaptation to environmental
stress (Jolly et al., 1997; Denegri et al., 2002; Jolly et al., 2004; Eymery et al., 2010),
however their role in heterochromatin formation is less clear.

1.3.5

Mitotic Checkpoints

Mitotic entry is ultimately controlled by the G2 DNA-damage checkpoint, which acts as a
surveillance mechanism to ensure genomic integrity prior to cell division. Lesions of
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DNA damage activate the PI3K (phosphoinositide 3-kinase)-related protein kinases ATM
and ATR, which phosphorylate and activate the CHK1/CHK2 effector kinases [reviewed
in (Chen et al., 2003)]. Active CHK1/CHK2 phosphorylate and inactivate CDC25C,
preventing dephosphorylation and activation of cyclin B1-CDK1.

Other signaling

pathways are critical for the G2 DNA-damage checkpoint, including the MAPKAPK2
[MAPKAP (MAPK-activated protein) kinase-2] and JNK (c-Jun N-terminal kinase)
pathways which act through the phosphorylation and inactivation of CDC25B. Mitosis is
initiated by the activation of the M-phase promoting factor (MPF), a heterodimer of
cyclin B1-CDK1 (cyclin-dependent kinase 1). Activation of the MPF is achieved by
PLK1 (polo-like kinase 1)-mediated phosphorylation of cyclin B1 and CDC25
phosphatase-mediated dephosphorylation of CDK1, which function to retain the MPF in
the nucleus, and activate its kinase activity respectively [Reviewed in (Stark and Taylor,
2006)]. The MPF is a Serine/Threonine (Ser/Thr) protein kinase with many substrates
involved in mitotic initiation and progression, including nuclear lamins, condensins,
microtubule associated proteins, and histones.
The separation of sister chromatids during anaphase is blocked by the spindle assembly
checkpoint (SAC), which functions to ensure the accurate segregation of chromosomes
during mitosis (Musacchio and Salmon, 2007; Cheeseman and Desai, 2008). To achieve
this, the checkpoint blocks chromosome segregation until every kinetochore has been
correctly bound by spindle microtubules. The mechanism governing this checkpoint is
believed to rely on diffusible signaling emanating from unattached kinetochores that
target Cdc20, an essential activator of the anaphase-promoting complex/cyclosome
(APC/C).

Prior to anaphase, Mad2 (mitotic-arrested deficient), BubR1 (budding

uninhibited by benzimidazole), Bub3 and Cdc20 itself are assembled into the mitotic
checkpoint complex (MCC) at the kinetochore. The MCC is diffusible throughout the
cytoplasm, and binds the anaphase promoting complex/cyclosome (APC/C), preventing
APC/C activation by Cdc20. This prevents cells from entering anaphase by inhibiting the
ubiquitination and destruction of cyclin B and securin by Cdc20 dependent activation of
the APC/C ubiquitin ligase (Musacchio and Salmon, 2007). Securin prevents anaphase
onset by binding and sequestering the cysteine protease separase, which, when active, can
target and cleave the cohesin subunit Rad21, opening the cohesin ring and allowing sister
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chromatid separation (Sun et al., 2009). Defects in the SAC can lead to chromosome
non-disjunction and aneuploidy due to premature anaphase onset without chromosome
biorientation (Fang and Zhang, 2011).

1.3.6

Cytokinesis

Cytokinesis is the final stage of the mitotic process that culminates in a membrane-fusion
event that produces two physically distinct and genetically identical daughter cells, each
possessing a diploid (2N) complement of chromosomes. Following the segregation of
the replicated sister chromosomes to the opposing poles of the mitotic cell, the two
diploid genomes, along with a complement of organelles, cytosolic factors, and plasma
membrane components, are physically partitioned into two discrete and fully functional
cells.
The first major step in cytokinesis is the accurate placement and ingression of the
actomyosin ring, ensuring that the segregated genomes are properly inherited by the two
daughter cells.

Cleavage furrow ingression involves the contractile activity of the

actomyosin ring, made of the actin motor protein non-muscle myosin II and a network of
cortical actin filaments. This ring assembles at the equatorial cell cortex on the inner
surface of the plasma membrane, and contracts in due to ATP dependent myosin II
activity in response to the active form of the small GTPase RhoA, which is enriched in a
narrow zone on the cell cortex where the future cleavage furrow will form (Bement et al.,
2005). To establish this precise domain of active RhoA the mitotic spindle positions
upstream RhoA activators, the GDP-GTP exchange factor (GEF) ECT2/Pebble, and the
GTPase-activating protein (GAP) MgcRacGAP/CYK-4/RacGAP50C at the central
spindle (Somers and Saint, 2003; Piekny et al., 2005). Active RhoA in turn regulates
actin polymerization and myosin II activation, promoting the contractile function of the
actomyosin ring. The positional signal for cleavage furrow induction is believed to
emanate from the central spindle, which is the region of overlapping microtubules from
each spindle pole at the cell equator [Reviewed in (Glotzer, 2004)].

Cleavage furrow

ingression continues until the actomyosin contractile ring comes within a close proximity
of the central spindle. A number of proteins found at the central spindle are critical
regulators of cytokinesis, either through the regulation of microtubule function, or
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through discrete signaling pathways. One such signaling protein is the mitotic kinase
PLK1.

At the midzone, Plk1 phosphorylates a number of substrates, including the

kinesin microtubule motor proteins MKLP2 and the dynein component NudC (Zhou et
al., 2003; Neef et al., 2003). This phosphorylation is essential for the normal completion
of cytokinesis, and overexpression of dominant negative Plk1 leads to cytokinetic failure
and multinucleation. Plk1 is also required for cleavage furrow ingression by regulating
the localization of RhoA to the cleavage furrow cortex (Petronczki et al., 2007; Brennan
et al., 2007). The actomyosin ring however cannot continue ingressing and cleave the
cells in two, rather the dense network of microtubules that were the central spindle are
condensed into the cytokinetic midbody, an intercellular bridge structure required for the
final stages of cytokinesis [Reviewed in (Eggert et al., 2006)]. Proteomic analysis of
midbodies has identified over a hundred different proteins, many of which have
subsequently been shown to be essential for abscission (Skop et al., 2004).
The final step in cytokinesis is a membrane abscission event that yields two physically
independent cells, and involves poorly understood protein degradation pathways and
plasma membrane vesicle trafficking. Membrane vesicles accumulate in the cleavage
furrow and intercellular bridge, and key membrane trafficking proteins, including
SNAREs [SNAP (soluble N-ethylmaleimide-sensitive fusion protein-attachment protein)
receptors], dynamin, and clathrin, localize to the cleavage furrow and intercellular bridge
[Reviewed in (Neto et al., 2011)]. Inhibition of the midbody-localized membrane vesicle
transport proteins (the t-SNARE/v-SNARE pair syntaxin 2 and endobrevin/VAMP-8) by
dominant-negative overexpression blocks the completion of cytokinesis in mammalian
cells, but does not affect earlier events such as cleavage furrow ingression (Low et al.,
2003), highlighting the importance of membrane trafficking in the terminal stages of
cytokinesis. One view of membrane trafficking in this context may be to ensure delivery
of key components to the midbody in the correct temporal sequence. An alternative role
for vesicle accumulation in the midbody prior to abscission is to deliver additional
membrane area, such that upon fusion with each other and the PM there is a thinning and
extension of the intercellular bridge (Neto et al., 2011).
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Completion of cytokinesis is also intimately linked with prior events in the mitotic cycle.
One well-documented cause of cytokinetic failure is the presence of chromosome bridges
spanning the cytoplasmic bridge during cytokinesis (Shi and King, 2005). These bridges
are believed to be a consequence of earlier mitotic abnormalities, including chromosome
fusions or chromosome misalignment and nondisjunction, which often result in DNA
damage, aneuploidy or tetraploidy (Shi and King, 2005). It is thought that the cytokinetic
block in these cases is due to genoprotective pathways that detect chromosome
missegregation and DNA damage and prevent the completion of cytokinesis by blocking
and reversing cleavage furrow ingression (Tutt et al., 1999; Lin et al., 2003b; Daniels et
al., 2004; Meng et al., 2007).

1.4
1.4.1

Mammalian Cerebral Cortical Development
The Mammalian Central Nervous System

The mammalian central nervous system (CNS) comprises the brain and spinal cord, and
functions to integrate sensory information from the peripheral nervous system (PNS), and
coordinate the activity of the body. Mammalian neural development begins with the
formation of the neural tube, the precursor to the brain and spinal cord. In the mouse, this
process (known as neurulation) begins at embryonic day 8.5 (E8.5) and ends at E11.5 and
involves the invagination, folding, and closure of a specialized strip of dorsal ectoderm
called the neural plate [Reviewed in (Colas and Schoenwolf, 2001)]. The ensuing neural
tube is then regionalized and subdivided, with the brain forming from the anterior-most
region. The brain is subdivided along the anterior-posterior axis into the prosencephalon
(forebrain) and brain stem (midbrain & hindbrain). The anterior most segment of the
forebrain becomes the embryonic telencephalon, which eventually develops into the
cerebrum, containing the striatum, hippocampus, and cerebral cortex of the mature brain.
The cerebrum is the most complex region of the adult mammalian brain, and is
responsible for many higher-order cognitive functions, including motor coordination,
conscious thought, learning, memory, emotions, speech and language in humans. Not
surprisingly, pathologies affecting the cerebrum are associated with cognitive and
behavioural deficits, and intellectual disability (Vaillend et al., 2008).
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1.4.2

Cortical Neurogenesis

Neurogenesis is the process of neuron production by neuronal progenitor cells. In the
mouse, the neurogenic interval is the period during embryonic development where
differentiated cortical neurons are being produced that begins at E11 and terminates at
E17 (Takahashi et al., 1995).
The neural tube begins as a single pseudostratified layer of cells known as the
neuroepithelium, which composed of neuroepithelial cells, the progenitors of every
neuron in the adult CNS. In the dorsal telencephalon, where the cerebral cortex is
formed, the neuroepithelium is known as the ventricular zone (VZ).

Prior to

neurogenesis the neuroepithelial progenitors proliferate through symmetric cell divisions
to expand the population of progenitor cells. During the early stages of neurogenesis, the
neuroepithelial cells of the VZ begin to divide asymmetrically, producing the earliest
born neurons of the cortex, and two other progenitor populations: radial glial cells, and
apical progenitors. Radial glial cells are distinguished from neuroepithelial cells by the
expression of an array of glial-specific markers, but share many properties, including the
undertaking of cell division at the ventricular surface (Kriegstein and Götz, 2003; Huttner
and Kosodo, 2005). Radial glial cells in turn give rise to most of the projection neurons
of the cerebral cortex, either directly through asymmetric cell division, or indirectly
through the generation of another type of progenitor cell, the basal progenitors (BPs).
Basal progenitors are distinguished from apical progenitors (neuroepithelial cells and
radial glia) because they undergo cell division in the sub-ventricular zone (SVZ) on the
basal side of the VZ and typically divide symmetrically, only once, producing two
neurons and thus amplifying the neuronal output of the radial glia (Noctor et al., 2004;
Haubensak et al., 2004; Miyata et al., 2004). The mature mammalian cerebral cortex is
composed of six morphologically distinct cellular layers (I, II, III, IV, V, VI), each
populated by neurons that project to specific regions within the cortex, midbrain, and
spinal cord. This lamination is achieved through the temporal regulation of neuron
production in the two germinal zones, the VZ and SVZ, and their controlled migration of
neurons to specific regions depending on the developmental stage. The earliest born
post-mitotic neurons migrate to the deepest cortical layers and later-arising neurons
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migrate past them to sequentially more superficial layers in a stereotyped ‘inside-out’
pattern (Sidman and Rakic, 1973; Caviness, 1982).

1.4.3

The Mode of Cell Division Regulates Neurogenesis in the
Developing Cerebral Cortex

The apical, but not basal progenitor cells are highly polarized along their apicobasal axis,
and this polarity is the basis of their symmetric or asymmetric cell division (Figure 1-2;
Figure 1-3) (Götz and Huttner, 2005; Farkas and Huttner, 2008). It has been shown that
the angle of progenitor cell division relative to the apical cell surface could largely
predict the outcome of the cell division, either proliferative or neurogenic (Kosodo et al.,
2004). Because of this, it has been proposed that apical progenitor cell fate is determined
primarily by the differential inheritance of specific cellular constituents to the daughter
cells (Figure 1-3) (Wodarz and Huttner, 2003; Götz and Huttner, 2005; Huttner and
Kosodo, 2005). The apical plasma membrane has been shown to serve such a role: in
predicting the cell fate outcome of apical progenitor cell divisions, where inheritance of
the apical membrane correlates with the preservation of progenitor cell identity (Kosodo
et al., 2004).

Although the apical plasma membrane of the apical progenitor cells

represents only a tiny fraction of the total cell surface, it is enriched for unique proteins
not found on the basolateral membrane. The PAR-3 (partitioning defective 3 homolog)
protein is found at the apical membrane, and compromising PAR-3 expression prevents
progenitor self-renewal by causing both daughter cells to exit the cycle and become
neurogenic (Costa et al., 2008).

Another candidate protein is Prominin-1, a

transmembrane protein expressed in the apical plasma membrane of many somatic stem
cells, including neuroepithelial progenitors and radial glia (Corbeil et al., 2001). The
protein interacts with membrane cholesterol, and it has been proposed that apical
neuronal progenitor proliferation may involve a poorly understood, cholesterol-dependent
mechanism at the apical membrane (Götz and Huttner, 2005).

Ultimately, the

mechanisms by which these and other potential determinants promote a progenitor-cell
fate in neuroepithelial cells are not currently established.
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Figure 1-2. The cell biological features of apical and basal progenitors during cell
division.
The aspects of apical neuronal progenitor cell polarity compared to basal progenitor cells
are illustrated (see legend for details). Importantly, the apical neuronal progenitors are
polarized and possess a distinct apical plasma membrane. In contrast, basal neuronal
progenitors do not show this type of apical membrane polarization. This difference in
membrane organization between these two types of neuronal progenitor cells is thought
to influence the symmetry of mitotic cell division and the fate of daughter cells (see Fig
1-3).
Reproduced with permission from Farkas et al. (2008) Curr Opin Cell Biol 20:707-715.
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Symmetric self-renewing divisions predominate early during neurogenesis and ultimately
expand the progenitor cell population, while asymmetric differentiative divisions become
more frequent as neurogenesis proceeds. A disruption in the balance and timing of
neurogenic versus proliferative cell divisions can have dramatic results on neuronal
output (Caviness et al., 2003).

For example, a premature initiation of neurogenic

divisions will initially increase the number of early born neurons in the deep cortical
layers at the expense of the superficial layers, and result in a smaller cortex. In contrast, a
delay in the onset of neurogenesis can lead to the opposite effect (Caviness et al., 2003).
A number of centrosomal proteins have been implicated in the regulation of cortical size
through control of mitotic spindle angle during apical progenitor cell division. Mutations
in the human homologs of a number of these centrosomal proteins are associated with a
neurodevelopmental disorder called autosomal recessive primary microcephaly (MCPH)
(Woods et al., 2005). Microcephaly is the clinical finding of reduced skull circumference
(which closely correlates with reduced brain volume) three standard deviations below the
mean (-3SD) for age and gender (Aicardi, 1998), and is often associated with mental
retardation, with the severity microcephaly being strongly correlated with the risk and
severity of mental retardation (Dolk, 1991).

Individuals with MCPH have intellectual

disability, and show a reduction of brain growth in utero, with the cortex being the most
affected, however overall brain structure is normal (Roberts et al., 2002).

Primary

microcephaly is generally non-progressive and is thought to result from defective
neurogenic mitosis during development, leading to a reduction in the number of neurons
(Dobyns, 2002; Woods et al., 2005).

Conversely, secondary microcephaly, which

develops after birth, is believed to be caused by processes such as high rates of pathologic
apoptosis, proliferation and patterning abnormalities, migration defects, disturbance of
extracellular matrix integrity, and defects of synaptogenesis, and is often a progressive
neurodegenerative condition (Woods et al., 2005). Currently, four MCPH related genes
have

now

been

identified:

autosomal

recessive

primary

microcephaly

(MCPH1/Microcephalin), abnormal spindle-like microcephaly associated

30

1

Figure 1-3. A comparison of symmetric and asymmetric cell division of
neuroepithelial and radial glial cells.
The relationship between cell polarity and the equal or unequal partitioning of the apical
membrane upon (a) symmetric or (b, c) asymmetric cell division, is shown. (a) A vertical
cleavage plane results in the partitioning of the apical membrane to both daughter cells
and symmetric, self renewing cell division. (b, c) Horizontal cleavage planes result in the
asymmetric inheritance of the apical membrane by a single daughter cells and leading to
neurogenic differentiation of the other.
Reproduced with permission from Götz and Huttner (2005) Nat Rev Mol Cell Biol (6):
777-788.
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(MCPH5/ASPM), cyclin-dependent kinase 5 regulatory subunit-associated protein 2
(MCPH3/CDK5RAP2) and centromere protein J (MCPH6/CENPJ). All four MCPH
genes are expressed in the neuroepithelium of the developing brain, three are centrosomal
components (ASPM, CENPJ, CDK5RAP2), and one (Microcephalin) is associated with
chromatin, which has lead to the hypothesis that MCPH is primarily a result of the
disruption of neurogenic mitosis (Jackson et al., 2002; Bond et al., 2003; Bond et al.,
2005; Woods et al., 2005).

Knockdown of ASPM expression using in vivo RNAi

electroporation in the developing embryonic mouse forebrain increases the number of
asymmetrically oriented mitotic progenitor cells which in turn correlates with an increase
of non-progenitor daughter cell fate (Fish et al., 2006). Interestingly, ASPM is naturally
downregulated by apical neuronal progenitors undergoing asymmetric neurogenic
divisions, suggesting that regulation of ASPM expression is a mechanism used to govern
the balance and timing of neurogenetic cell divisions (Fish et al., 2006).
Another MCPH-associated gene, cyclin-dependent kinase 5 regulatory subunits 2
(CDK5RAP2), encodes a centrosomal protein with a role in γ-tubulin ring complex (γTuRC) recruitment and microtubule nucleation at the centrosome (Fong et al., 2008).
The cortex of the CDK5RAP2 null mouse is severely dysmorphic, with cortical
hypoplasia, and reduction in brain and hippocampal size (Lizarraga et al., 2010). The
cortex is characterized by a loss of later born superficial layer (II/III) neurons and an
increase in early born neurons of the deep cortical layer (VI). The apical progenitors
show defects in mitotic spindle positioning, with an increase in the proportion of
horizontal/asymmetric cell divisions and a premature depletion of the neuronal progenitor
cell population.
Cytokinesis has also been found to influence the cellular control of cortical development.
Mutations in the citron kinase (CitK) gene cause microcephaly in mice and rats, and the
mutant cortex is characterized by binucleated cells and massive apoptosis in the
proliferative zones of the embryonic cortex (Di Cunto et al., 2000; Sarkisian et al., 2002).
Citron kinase is localized to the cytokinetic midzone and cleavage furrow during
anaphase and telophase and then translocates to the cytokinetic midbody during
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cytokinesis (Di Cunto et al., 1998; Eda et al., 2001). Furthermore, overexpression of
truncated mutant isoforms causes erratic cytokinetic behaviour and cytokinesis failure in
HeLa cells (Madaule et al., 2000). Taken together, mitotic cell division is clearly a
critical regulator of brain size and neurogenesis through the partitioning of cell fate
determinants and maintenance of cell viability.

1.5

Thesis Overview

The objective of the work presented in this thesis was to determine whether the chromatin
remodeling protein ATRX is required for normal mitotic cell division and whether this
requirement is relevant in the proliferating cells of the developing embryonic mouse
brain.

1.5.1

Rationale and Hypothesis

Although ATRX is a known transcriptional regulator, many studies have confirmed its
enrichment at the highly condensed, gene-poor region of PCH flanking the centromere.
In most cells ATRX is recruited to PCH by HP1, an integral component of PCH that is
required for the epigenetic maintenance of heterochromatin. I therefore hypothesized that
ATRX is an essential component of PCH, and a deficiency in ATRX would lead to
mitotic abnormalities and chromosome alignment and segregation errors (Chapter two
and three). The mitotic defects observed in ATRX-deficient HeLa cells inspired a second
hypothesis, that this mitotic requirement might also exist in the neuroepithelial
progenitors of the developing mouse forebrain, and may be relevant to the
neurodevelopmental abnormalities in the Atrx-null mouse (Chapter four).

1.5.2

Chapter Two: Loss of ATRX Leads to Chromosome
Cohesion and Congression Defects

This initial study aimed to determine the possible mitotic requirement for ATRX in
mammalian somatic cells.

At the time this study was conceived and initiated, a

requirement for ATRX in meiotic chromosome alignment had recently been shown in
2004 (De La Fuente et al., 2004), establishing a proof of principle for this study. To
achieve this aim, HeLa cells were depleted of ATRX using different RNAi strategies, and
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scored for mitotic abnormalities using techniques for both fixed and live-cell imaging.
This study showed not only a mitotic disruption, but it revealed that sister chromatids
from mitotic ATRX-depleted HeLa cells had greatly reduced centromeric cohesion,
identifying a particular mechanism that might underlie the observed mitotic defects.
Furthermore I found evidence of mitotic defects in the neuroepithelial progenitors in the
developing Atrx-null mouse cortex in vivo, suggesting that this mitotic requirement exists
in a biologically relevant tissue.

1.5.3

Chapter Three: Cytokinetic Abnormalities and
Multinucleation Induced by ATRX Depletion

Chapter three is an extension of the study conducted in chapter two. Although mitotic
chromosome congression, alignment, and segregation were disrupted in the ATRXdepleted HeLa cells, live cell imaging revealed that these cells also had dramatically
prolonged cytokinesis, which more frequently failed and produced binucleated cells.
Assessment of cytokinetic midbody structure in these cells using immunofluorescent
staining revealed that ATRX does not influence the formation or integrity of the
cytokinetic midbody. This study suggests that a deficiency in ATRX leads to cytokinetic
abnormalities and failure through an indirect mechanism, likely related to chromosome
nondisjunction.

1.5.4

Chapter Four: ATRX Regulates Cortical Development
Through Control of Neuronal Progenitor Cell Division

The final aspect of my studies aimed to identify whether ATRX-dependent mitotic cell
division contributed to the neurodevelopmental phenotype of the Atrx-null mouse. Using
a combination of primary cell culture and histological sectioning, I confirmed that
neuronal progenitors from the Atrx-null forebrain exhibited mitotic defects identical to
those observed in the ATRX-depleted human cells, including chromosome misalignment
and missegregation. Furthermore, these cells were more often asymmetrically oriented
during cell division in vivo and this correlated with a predictably altered neuronal output
in the postnatal brain, characterized by a depletion of the late developmental stage
neuronal progenitors and late born cortical neurons. The work presented in this thesis
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represent the first studies to show a mitotic requirement for the ATRX protein, and the
first to link such a requirement to a specific neurogenic role for the Atrx gene.

1.6
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Chapter 2

2

Loss of ATRX Leads to Chromosome Cohesion and
Congression Defects

In 2005, prior to undertaking the research presented in this chapter, the ATRX protein
had been studied almost exclusively in the context of gene regulation. However in 1999
it was surprisingly reported that ATRX is highly enriched at PCH in mouse and human
somatic cells (McDowell et al., 1999), and in mouse oocytes in 2004 (De La Fuente et al.,
2004). The highly condensed domains of PCH on each chromosome are devoid of
traditional mRNA producing genes, but are required structurally to ensure the proper
interaction of the centromere with the mitotic spindle. Subsequently it was reported that
ATRX was required for normal chromosome alignment on the metaphase II (MII)
meiotic spindle (De La Fuente et al., 2004), however a similar requirement in somatic
cells had not yet been reported. In this chapter I sought to investigate whether ATRX
was required for normal chromosome alignment during mitotic cell division in human
and mouse somatic cells.
This chapter was previously published as (Ritchie et al., 2008).

Permissions for

reproduction are found in Appendix 1.

2.1

Introduction

ATRX is a chromatin-remodeling enzyme implicated in early development of several
organs, particularly the central nervous system (CNS).

The ATRX protein contains

conserved domains suggestive of a role in the epigenetic regulation of chromatin
structure and function, including a plant homeodomain-like zinc finger domain shared
with de novo methyltransferases (DNMT3A/B, 3L) and a SWI/SNF family ATPase
domain.

ATRX has the ability to remodel chromatin and displays ATP-dependent

translocase activity (Xue et al., 2003).

It is highly enriched at pericentromeric

heterochromatin (PCH) in mouse and human cells (McDowell et al., 1999) and associates
directly with the chromoshadow domain of heterochromatin protein 1α (HP1α) (Lechner
et al., 2005). It is also targeted to promyelocytic leukemia nuclear bodies (PML-NBs) by
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the C-terminal portion of the protein (Bérubé et al., 2008). Atrx loss of function in the
mouse starting at the 8 to 16 cell stage is embryonic lethal (Garrick et al., 2006), and
conditional ablation of the full-length ATRX isoform in the mouse forebrain results in
decreased cortical size at birth (Bérubé et al., 2005). Although ATRX has been proposed
to regulate gene transcription, the protein appears to be hyperphosphorylated and highly
enriched at condensed chromosomes during mitosis in human cells, suggesting an
additional function during this stage of the cell cycle (Bérubé et al., 2000).
The faithful segregation of chromosomes during mitosis requires the physical linkage of
sister chromatids from S-phase until the onset of anaphase. The ring-shaped cohesin
multiprotein complex is required for the maintenance of sister chromatid cohesion, and
plays a role in the proper separation and segregation of sisters during anaphase (Hirano,
2005). Cohesin at the chromosomal arms is released during prophase by the Polo and
Aurora B kinases and the chromatin protein wings apart-like (Wapl) (Sumara et al., 2002;
Kueng et al., 2006; Gandhi et al., 2006). Cohesion at pericentromeric heterochromatin is
protected by the Shugoshin (Sgo) family of proteins and prohibitin 2 (PHB2) and
consequently persists until all the chromosomes are bi-oriented at the metaphase plate
(McGuinness et al., 2005; Kitajima et al., 2006; Takata et al., 2007). Only then is the
spindle checkpoint satisfied, resulting in the activation of the anaphase-promoting
complex/cyclosome (APC/C) and subsequent cohesin cleavage by the thiol protease
separase.
Stable loading of cohesin onto chromatin before DNA replication is mediated by the
Scc2-Scc4 heterodimer in yeast (Ciosk et al., 2000; Watrin et al., 2006). Human Scc2,
known as NIPBL (Delangin), mediates cohesin transfer onto chromatin during S phase
and, like ATRX, associates with the chromoshadow domain of HP1α (Lechner et al.,
2005).

Chromatin remodeling proteins have been implicated in chromosome cohesion.

The Sth1 subunit of the yeast RSC chromatin remodeling complex has been shown to
participate in cohesin loading on chromosomal arms, but not at the centromere (Baetz et
al., 2004; Huang et al., 2004). In human cells, the SNF2h/ISWI chromatin remodeling
protein, a component of several remodeling complexes, was shown to participate in
cohesin recruitment to specific sites on chromosome arms (Hakimi et al., 2002).
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ATRX mutations in humans cause mental retardation and microcephaly (Gibbons et al.,
1995; Picketts et al., 1996).

Given that Atrx loss of function in the mouse forebrain

results in reduced cortical mass (Bérubé et al., 2005) and that the protein becomes
hyperphosphorylated at the onset of mitosis (Bérubé et al., 2000), we postulated that
ATRX could have specific functions during mitosis. We now provide evidence that the
SWI/SNF-like chromatin remodeling protein ATRX is required for normal chromosome
congression, cohesion and segregation in human cultured cells.

Loss of ATRX in

neuronal progenitors by Cre/loxP recombination in vivo also resulted in abnormal
chromosome segregation, as evidenced by the high incidence of micronuclei and
dispersed chromosomes. Mitotic dysfunction could induce cell death in the developing
brain and/or cause a reduction in symmetric cell divisions, therefore reducing the
progenitor pool. Either of these scenarios or a combination thereof would be predicted to
reduce cortical size at birth.

2.2
2.2.1

Materials and Methods
Cell Culture and Transfection

HeLa cells (ATCC) and HeLa-H2B-GFP cells (GM Wahl, The Salk Institute, La Jolla,
CA 92037) were grown at 37oC with 5% CO2 in Dulbecco’s Modified Eagle’s Medium
supplemented with 10% fetal bovine serum (Sigma-Aldrich, St. Louis, MO). HeLa-H2BGFP growth media was supplemented with 2µg/ml Blasticidin S HCl (Invitrogen,
Carlsbad, CA) to maintain transgene expression. For siRNA transfection, cells were
seeded 24 hours prior to transfection using Lipofectamine 2000 following the
manufacturer’s instructions (Invitrogen). The final siRNA concentration used in all
experiments was 8nM. In HeLa cells, the transfection efficiency was approximately 9095% based on immunofluorescence detection of the ATRX protein isoforms.

For

population synchronization at G1/S, transfected cells were incubated with hydroxyurea
(10µM) and released after 16 hours by removal of the drug.

2.2.2

RNA Interference

The synthetic oligonucleotides siATRX1 (5’-GAGGAAACCUUCAAUUGUAUU-3’),
siATRX2 (5’- GCAGAGAAAUUCCUAAAGAUU-3’) and siATRX1 Scrambled (5’-
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GAUUGAAGACUGAUAUCACUU-3’) were obtained from Dharmacon (Lafayette,
CO). Control (non-targeting) siRNA duplex was obtained from Sigma. siRNA duplexes
were transfected with Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
instructions. Mock-transfected samples were treated similarly but without addition of
siRNA.

2.2.3

Western Blot Analysis

Cells were lysed with RIPA buffer [150 mM NaCl, 1 % NP-40, 50 mM Tris pH 8.0, 0.5
% deoxycholic acid, 0.1 % SDS, 0.2 mM phenylmethylsulfonyl fluoride (PMSF), 0.5
mM NaF, 0.1 mM Na3VO4, 1 protease inhibitor cocktail tablet (Complete Mini, EDTAfree, Roche Diagnostics GmbH, Mannheim, Germany)] for 5 min on ice. Extracts were
sonicated and quantified using the DC Protein Assay (Bio-Rad, Hercules, CA). Protein
(20 µg) was resolved on 6 % or 12 % SDS-PAGE and transferred onto nitrocellulose
membranes (Bio-Rad). The membranes were probed with rabbit α-ATRX H300 (Santa
Cruz Biotechnology, Santa Cruz, CA), mouse α-ATRX 39f (gift of D.J. Picketts and D.
Higgs, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford,
UK), followed by appropriate horseradish peroxidase-conjugated secondary antibody
(Amersham Biosciences, Quebec, 1:5000). After washing, the membrane was incubated
in ECL before exposure to X-ray film. The membrane was re-probed with mouse α-antitubulin (Sigma; 1:40,000) as a loading control.

2.2.4

Quantitative Reverse-Transcriptase Polymerase Chain
Reaction (Q-RT-PCR) Analysis

Total RNA was isolated using the RNeasy Mini kit (QIAGEN, Valencia, CA). Firststrand cDNA was synthesized from 3 µg of total RNA using random primers and a
reverse transcriptase (RT) cocktail containing 5X first strand buffer, 100 mM DTT, 25
mM dNTPs, RNA guard and Superscript RT. PCR reactions were performed on a
Chromo4 Continuous Fluorescence Detector (MJ Research) in the presence of iQTM
SYBR Green supermix (Bio-Rad) and analyzed with Opticon Monitor 3 and GeneX
software (Bio-Rad) using the standard curve Ct method of quantification. Samples were
o

o

o

amplified as follows: 95 C for 30 sec, 55 C for 30 sec, 72 C for 30 sec. After 30 cycles,
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a melting curve was generated to visualize amplicon purity.

Standard curves were

generated for each primer pair using fivefold serial dilutions of control cDNA. Primer
efficiency was calculated as %E = [(10

-1/slope

) – 1]x100, where a desirable slope is –3.32

and r2>0.99. All data was normalized GAPDH expression levels. The primers used for
Q-RT-PCR were as follows: ATRX-F: 5’-TCCTTGCACACTCATCAGAAGAATC-3’
ATRX-R: 5’-CGTGACGATCCTGAAGACTTGG-3’ GAPDH-F: 5’-GAGTCAACGG
ATTTGGTCGT-3’ GAPDH-R: 5’-GACAAGCTTCCCGTTCTCAG-3’.

2.2.5

Flow Cytometry

Exponentially growing cells were harvested, washed with CMF PBS (NaCl 137mM, KCl
2.7mM, Potassium Phosphate Monobasic 1.5mM, Sodium Phosphate Dibasic 12mM)
three times and 1.5x106 cells fixed drop wise with 90% ethanol and stored at 4ºC for at
least 12 hours. To detect DNA content, cells were washed and stained with propidium
iodide/RNase staining solution (10µg/ml PI), 250µg/ml RNase A (Sigma) 2% BSA in
CMF PBS for 30 min at room temperature, followed by overnight incubation at 4oC. Cell
populations were analyzed by flow cytometry on a Beckman-Coulter EPICS XL-MCL
instrument. Data analysis to determine the proportion of cells in each phase of the cell
cycle was carried out using the Expo 32 software package (Beckman Coulter).

2.2.6

Indirect Immunofluorescence Microscopy

For immunofluorescence detection, cells were fixed with EtOH:MeOH (3:1) up to four
days following siRNA transfection and incubated with the following primary antibodies:
α-ATRX H300 antibody (Santa Cruz, 1:200), α-ATRX 39f antibody (D.J. Picketts,
Ottawa Health Research Institute, Ottawa, Canada; 1:20)

α-alpha tubulin (Sigma,

1:1500), α-phosphohistone H3(S10) (Upstate, Billerica, MA; 1:200) human α-CREST
(W. Brinkley, Baylor College of Medicine, Houston, TX; 1:10000)

α-BubR1 (BD

Transduction Labs, 1:200), α-Bub1 (a gift from S. Taylor, University of Manchester,
Manchester, UK, M13 9PT; 1:1000), α-CENP-E (Santa Cruz; 1:400), α-CENP-F (S.
Taylor 1:100), α-HP1α (Upstate, 1:200), α-HP1β (Upstate, 1:200). Secondary antibodies
included goat α-rabbit Alexa 594 (1:1500), donkey α-rabbit Alexa 488 (1:1500) goat αmouse Alexa 488 (1:1500), goat α-mouse Alexa 594 (1:1500), and goat α-human Alexa
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647 (1:1500) (Invitrogen). Coverslips were mounted with Vectashield H-1000 (Vector
Laboratories).

2.2.7

Generation of ATRX-depleted Stable Clones

Pairs of sense 60-mer oligonucleotides corresponding to the 19-mer siATRX1 and
siATRX2 siRNA target sequences and their reverse complement (underlined sequences)
were designed that contained 5’ BglII and 3’ HindIII restriction sites to facilitate cloning
(Integrated DNA Technologies, Inc):.shATRX1 (sense) 5’-GATCCCCGAGGAAACCT
TCAATTGTATTCAAGAGATACAATTGAAGGTTTCCTCTTTTTA-3’ and shATRX2
(sense) 5’-GATCCCCGCAGAGAAATTCCTAAAGATTCAAGAGATCTTTAGGAAT
TTCTCTGCTTTTTA-3’. The oligonucleotides were annealed to complimentary antisense 60-mer oligonucleotides in buffer containing 10mM Tris pH 7.5, 50 mM NaCl, and
1 mM EDTA at 90ºC for 4 min, followed by 70ºC for 10 min, then step cooled to 37ºC
for 20 min using a thermocycler (MJ research) and cloned into the pSuper.retro.neo
plasmid (Oligoengine Inc.) using the Quick Ligation Kit according to manufacturer’s
instructions (New England Biolabs).

The resulting vectors, designated pSUPER-

shATRX1 and pSUPER-shATRX2, were subsequently sequenced to confirm sequence
identity. Exponentially growing HeLa-H2B-GFP were transfected with empty pSuper
vector or with pSuper-shATRX1 and pSuper-shATRX2 vectors (1µg/ml) using
Lipofectamine 2000 (Invitrogen). Two days after transfection, cells were replated at low
density and selection was applied 24 hours later (800µg/ml Geneticin, GIBCO). Drugresistant colonies were picked and expanded in selection media (400µg/ml Geneticin).

2.2.8

Time-Lapse and Live-Cell Microscopy

HeLa-HG, HG-pSuper, HG-shATRX1, or HG-shATRX2 cells were plated on 35mm
glass bottom tissue culture dishes (Mattek) in DMEM 10% FBS. After 24h, the media
was replaced with CO2-independent media (Gibco) supplemented with 10% FBS and
4mM L-glutamine (Sigma). For transient experiments, cells were plated and transfected
and scored 48-72h following transfection. Cells were imaged using a Leica DMI 6000b
automated inverted microscope equipped with a live cell stage-mounted environment
chamber (Neue Biosciences) to maintain the cells at 37°C during imaging.
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Phase

contrast and fluorescence (GFP) images were captured every 3 min for 10 hours using
Openlab Software automation (v5.0, Improvision). To measure mitotic duration, cells
that initiated mitosis (determined by nuclear envelope breakdown) and re-entered G1
(nuclear decondensation) within the time frame of the experiment (10 hours) were
analyzed (n>50). This analysis did not include cells that were arrested at pro-metaphase
or that died during the timeframe of the experiment. To measure the frequency of
unaligned chromosomes at metaphase, cells were seeded in 35mm culture wells (BD
Bioscience) in DMEM 10% FBS, and at least 500 metaphase cells were scored per
sample. For mitotic spindle checkpoint arrest, HeLa-HG or HG-shATRX1 cells were
treated with 100ng/ml nocodazole for 16 hours. Rounded mitotic cells and adherent
interphase cells were quantified using live cell microscopy (n>1000).

2.2.9

Fixed Chromosome Spreads

HeLa cells were transiently transfected with no siRNA duplex (mock), siATRX1
Scrambled (non-specific control), siATRX1, or siATRX2. Mitotically arrested cells were
removed by shake-off 70 hours following transfection and adherent cells were treated
with 100 ng/ml Karyomax Colcemid (Invitrogen) for 2 hours. Mitotic cells were then
isolated and incubated in hypotonic solution (75mM KCl) for 20 minutes, followed by
fixation in Carnoy’s Fix (3:1 MeOH:AcOH) and stored at -20°C. Fixed cells were
dropped onto Fisher Superfrost Plus glass microscope slides and air dried, DNA was
counterstained with DAPI (100ng/ml) and mounted in Vectashield H-1000 (Vector
Labs). For Z-stack imaging, 0.4 µm interval Z-stacks were captured and deconvolved
using iterative restoration with Volocity imaging software (v4.0 Improvision).

2.2.10

Measure of Interkinetochore Distances

To measure interkinetochore distance, mitotic HeLa-HG, HG-pSuper, HG-shATRX1 and
HG-shATRX2 stable cells were fixed in 3:1 EtOH:MeOH, the kinetochores were stained
using the human CREST antibody (1:10,000), and imaged using a 63x 1.4na oilimmersion objective.

Z-stacks were captured at 0.4µm z-intervals spanning 20µm.

Kinetochore pairs were connected from the outer edges of the CREST signal and the
distance measured using Volocity software (v4.0, Improvision). Only kinetochore pairs
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in single optical sections that were aligned at the metaphase plate were used to measure
interkinetochore distances (n≥100). Statistical differences were assessed by analysis of
variance (ANOVA).

Significant differences in mean interkinetochore distance were

assessed by Analysis of Variance (ANOVA) and a Tukey’s multiple comparison post hoc
test.

Differences were considered significant when p<0.05. Statistical analysis was

performed using Graph Pad Prism (v4.02).

2.2.11

Kinetochore Microtubule Assay

HeLa-HG, HG-pSuper, HG-shATRX1, or HG-shATRX2 cells were seeded in 35mm
dishes (Corning) in 2ml DMEM 10% FBS on 22mm2 glass coverslips (VWR scientific).
After 48h, the growth media was replaced with ice-cold growth media and the cells were
incubated on ice for 10 minutes. The cells were rinsed twice with ice cold PHEM buffer
(60mM piperazine ethanesulfonic acid, 45mM HEPES, 10mM EGTA, 2mM MgCl2, pH
6.9), permeabilized with cold 0.5% TritonX-100 in PHEM buffer for 3 minutes, and then
fixed in cold 3.5% paraformaldehyde in PHEM for 15 minutes. The coverslips were
rinsed with PHEM and processed for immunofluorescence staining and microscopy.

2.2.12

Analysis of Mitotic Cells in the Developing Telencephalon

The generation of AtrxloxP mice was described previously (Bérubé et al., 2005; Garrick et
al., 2006) and were obtained from D. Higgs and R. Gibbons (University of Oxford,
Oxford, UK, OX3 9DS). Male embryos conditionally deficient for Atrx were obtained by
crossing homozygous AtrxloxP females to heterozygous Foxg1Cre knock-in male mice and
embryonic yolk sac DNA from E13.5 embryos were genotyped by PCR as previously
described (Bérubé et al., 2005). Midday of the day of vaginal plug discovery was
considered as embryonic day 0.5. At scheduled times, pregnant females were
anesthetized by CO2 and sacrificed by cervical dislocation. Embryos and postnatal brains
were fixed in 4% paraformaldehyde/phosphate buffered saline (PBS) overnight at 4oC,
sunk in 30% sucrose in PBS and embedded in 15% sucrose and 50% OCT (Sakura
Finetek USA Inc.). Tissue sections were cut at 10 µm thickness and mounted on Fisher
SuperFrost Plus slides, air dried at room temperature and stored at –80oC. For
immunofluorescence staining, sections were thawed, rehydrated in PBS for 10 min,
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counterstained with DAPI and mounted in Vectashield (Vector Laboratories).
Micronuclei and misaligned chromosomes from the mitotic layer lining the lateral
ventricle were scored from both hemispheres of brain sections (n=3) in four litter
matched control (Foxg1Cre) and ATRX-null embryos using fluorescence microscopy.
Analysis was restricted to the mitotic layer that lines the hippocampal hem, hippocampal
primordium and the dorsal cortical neuroepithelium (indicated by the area between 1 and
2 in Figure 5C).

2.2.13

Details of Image Acquisition and Processing

All samples processed for microscopy were imaged using a Leica DMI 6000b automated
inverted microscope. Images were captured using a 63x 1.4NA and 40x NA 1.25 oil
immersion lens (Leica), or a 5x dry objective (Leica). For oil immersion microscopy, we
used Leica immersion oil with a refractive index of 1.518. All images were captured at
ambient temperature, except for image capture of live cells and time-lapse experiments,
which were performed at 37°C. Experiments used different combinations of DAPI, Goat
anti-rabbit Alexa 594, Goat anti-mouse Alexa 594, Donkey anti- rabbit Alexa 488, Goat
anti-mouse Alexa 488, and Goat anti-human 594 secondary antibodies.

Digital

microscopy images were captured with a Hammamatsu ORCA-ER digital camera.
Openlab (v5.0, Improvision) imaging software was used for manual and automated image
capture, and processing was performed using Volocity (v4.0, Improvision).

All

deconvolution was performed using iterative restoration set with a confidence limit of
95%.

2.3
2.3.1

Results
ATRX-depleted HeLa Cells Exhibit Unusual Nuclear
Morphology and DNA Bridging

The ATRX gene yields two major protein isoforms: a full-length 280kDa protein and a
truncated form, ATRXt, of 180kDa (Garrick et al., 2004). Both ATRX protein isoforms
exhibit an exclusive nuclear localization and are highly enriched at pericentromeric
heterochromatin (Figures 2-1A and 2-1C). We induced transient ATRX depletion in
HeLa cells by transfecting small interfering (si)RNAs. Cells were treated with two
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siRNA duplexes, siATRX1 and siATRX2, each designed to simultaneously silence the
full length and truncated ATRX proteins. Both duplexes caused substantial silencing of
ATRX isoforms as assessed by immunostaining (Supplementary Figure 2-1A), and this
was confirmed by quantitative reverse-transcriptase-PCR (Q-RT-PCR; Supplementary
Figure 2-1B) and Western blot analysis (Figure 2-1B). Co-immunofluorescence staining
of centromeres using the CREST antibody demonstrated that only minimal amounts of
ATRX protein are detectable at pericentromeric heterochromatin in siRNA-treated cells
(Figure 2-1C). We observed that the nuclei of depleted cells appeared lobulated and the
cells showed evidence of intranuclear DNA bridges and poorly resolved chromatin
masses during interphase (Figure 2-1D). We scored the number of abnormal nuclei at 48,
72 and 96 hours post-transfection and found an increased incidence of lobulated nuclei
and of intranuclear bridges (Figure 2-1E). Such abnormalities can be indicative of
mitotic defects and prompted us to further investigate the function of ATRX in mitosis.

2.3.2

Prolonged Prometaphase to Metaphase Transition upon
Downregulation of ATRX

To investigate the kinetics of mitotic progression, we assessed the outcome of both
transient and stable depletion of ATRX in HeLa cells that express histone H2B fused to
the green fluorescent protein, HeLa-H2B-GFP (HG). Stable clones were difficult to
expand, suggesting that reduced ATRX expression imparts negative effects on cell
division, proliferation, or viability. A negative impact on cell division was previously
reported upon conditional ablation of the full-length ATRX protein in embryonic stem
(ES), although the cause was not determined (Garrick et al., 2006) We chose two stable
cell lines for our analysis, designated shATRX1 and shATRX2, each expressing a
shRNA that targets a distinct sequence within the ATRX transcript. Both stable clones
expressed substantially reduced levels of ATRX RNA and protein as determined by QRT-PCR and Western blot analysis (Figure 2-2A).
Time-lapse videomicroscopy was used to evaluate the outcome of both transient and
stable ATRX silencing. We generated videos of live cells (10 hours) and from these,
measured the time required to complete each stage of mitosis (stable clone n=50;
transient depletion n≥120). This analysis revealed that ATRX-depleted cells took longer
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Figure 2-1. Transient ATRX depletion in HeLa cells induces abnormal nuclear
morphology.
(A) Immunofluorescence detection of ATRX (green) and the kinetochore marker CREST
(red) on prometaphase and metaphase chromosomes. (B) Western blot analysis of HeLa
cells transiently transfected with siATRX 19-mer duplexes demonstrate ATRX protein
depletion starting at 48 h and up to 96 h after transfection. ATRX protein levels remained
constant upon mock transfection and in cells transfected with a control siATRX
scrambled sequence duplex (left). Both ATRX isoforms were effectively silenced by 48 h
after transfection (right). α-Tubulin protein expression (αTub) was used as a control in all
experiments. Numbers on top of the blot indicate hours after transfection and numbers in
parenthesis indicate the molecular mass in kDa. (C) Co-staining of kinetochores and
ATRX with the CREST and 39f antibodies, respectively, reveals loss of ATRX protein at
PCH in siRNA-treated cells. (D) Cells stained with DAPI show abnormal nuclear
morphology in ATRX-depleted cells compared with control (scrambled siRNA) treated
cells. Common defects include lobulated nuclei and intranuclear DNA bridges (right). (E)
The number of nuclei displaying abnormalities was quantified at 48, 72, and 96 h after
siRNA treatment (n > 1,000 nuclei at each time point). Bars: (A and C) 5 µm; (D) 20 µm.
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than control siRNA transfected cells to undergo mitosis (Supplementary Figure 2-2) due
to an extended transition from prometaphase to a fully aligned metaphase (Figure 2B,
p<0.001). The delays in prometaphase were underestimated since a subset of mitotic
cells that were arrested at prometaphase or metaphase for the total duration of the
observation period (10 hours) were not included in this analysis. These chronically
arrested prometaphase cells often became non-adherent and/or died, as indicated by
membrane blebbing and highly condensed chromatin (Video S2-1). Taken together,
these results show that ATRX is required for the normal transition from prometaphase to
metaphase during mitosis.

2.3.3

ATRX Depletion Affects Chromosome Congression

The mitotic delay in ATRX-depleted cells occurred primarily between prometaphase and
metaphase, a time when condensed chromosomes are congressing toward the metaphase
plate. We noticed that metaphase plates in transiently depleted cells and in the shATRX1
and shATRX2 stable cell lines were often characterized by misaligned chromosomes or
by chromosomes that remained randomly distributed over the bipolar microtubule spindle
(Figure 2-2C and Video S2-2), suggesting that the prometaphase-to-metaphase delay
might be caused by impaired chromosome congression (chromosome movement
mediated by the mitotic spindle) to the spindle equator. To evaluate the extent of this
defect, we scored the number of metaphasic cells with misaligned chromosomes in
control siRNA transfected and ATRX-depleted live cell cultures. A greater proportion of
metaphase plates had misaligned chromosomes in the shATRX1 and shATRX2 depleted
clones compared to control HG-pSuper cells (Figure 2-2C and 2-2E). In addition, we
followed stably (shATRX1; n=100) and transiently (siATRX; n≥120) depleted mitotic
cells by videomicroscopy over a 10 hour period and observed an approximately 3-fold
(stable depletion) and 4-fold (transient depletion) increase in the number of cells
displaying congression defects in ATRX-depleted cells compared to control HG-pSuper
cells during that time period (Figure 2-2D). In addition, metaphasic cells often appeared
less condensed in ATRX-depleted cells and were sometimes observed to undergo
decondensation/recondensation (or mitotic rotation) prior to anaphase onset by live-cell
imaging (Figure 2-2E, middle panels and Video S2-3). We further confirmed the general
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Figure 2-2. Stable and transient depletion of ATRX extends the transition to
metaphase and induces congression defects.
(A) HeLa-HG cells that stably express pSuper-shATRX1, pSuper-shATRX2, or pSuper
(empty vector control) were generated and the level of ATRX depletion was measured by
Q-RT-PCR (top) and Western blot analysis (bottom). Q-RT-PCR results were normalized
to GAPDH expression and protein loading on the Western blot was controlled with αtubulin. Error bars represent the standard deviation from triplicate samples. (B) Mitotic
cells were followed in real time by videomicroscopy and the duration of prometaphase
was measured for pSuper control and HG-shATRX1 stably depleted cells (n = 50 each)
and also in transient transfections with siATRX1 (n > 120). Horizontal lines indicate the
mean value of each dataset. (C) The fraction of metaphasic cells with misaligned
chromosomes (inset) was evaluated in live cell cultures of HeLa-HG, HG-pSuper, HGshATRX1, and HG-shATRX2 stable clones (n = 100 for each). To score chromosome
misalignment, any visibly discrete GFP-positive signal that was distinct from the
metaphase plate was scored as a misaligned chromosome(s). (D) Live mitotic cells were
followed over a 10 h period and scored for congression defects in stable (n = 50) and
transient experiments (n > 120). (E) Selected panels from live cell videomicroscopy
experiments of control HeLa-HG cells and ATRX-depleted cells from nuclear envelope
breakdown (NEBD) to anaphase onset (AO). ATRX-depleted mitotic cells often
displayed misaligned chromosomes (arrowheads) that resolved before the onset of
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anaphase (middle), whereas, in some cases, anaphase was initiated despite the presence
of misaligned chromosomes (bottom). A subset of metaphase chromosomes underwent
cycles of general decondensation and recondensation, or mitotic rotation (the asterisk
indicates a decondensed metaphase plate). Numbers indicate minutes after NEBD. (F)
Morphological assessment of chromosome decondensation in control siRNA treated and
cells transiently depleted of ATRX. Graph depicts the percentage of metaphase spreads
that display a more decondensed appearance (far right). Bars: (C) 5 µm; (E) 16 µm, (F)
20 µm.

69

decondensed appearance of ATRX-depleted metaphasic chromosomes by staining
chromosome spreads with DAPI. The frequency of spreads with a staining pattern
indicative of more decondensed chromatin (wider chromosomes) was higher in cells
transiently depleted of ATRX using siATRX1 and siATRX2 duplexes (Figure 2-2F) than
in control siRNA treated cells. These results demonstrate that transient as well as stable
silencing of ATRX interferes with normal prometaphase-to-metaphase progression,
causes impaired chromosome congression and is sometimes accompanied by
chromosome decondensation.

2.3.4

Sister Chromatid Cohesion is Compromised in ATRX
Depleted Cells

Abnormal chromosomal congression could be caused by perturbed targeting of outer
kinetochore proteins to the centromere, spindle defects, abnormal pericentromeric
heterochromatin or reduced cohesion between sister chromatids. Congression defects
have been reported upon depletion of the outer-kinetochore proteins CENP-E and CENPF (mitosin) that are essential for stable MT-kinetochore capture (Yao et al., 1997; Wood
et al., 1997; McEwen et al., 2001; Yang et al., 2005). We examined the ability of CENPE and CENP-F to localize to kinetochores in ATRX depleted cells and found that both
proteins localized normally at the kinetochore of metaphasic cells (Figure 2-3A). The
loss of factors that control pericentromeric heterochromatin (PCH) structure can also
cause aberrant mitosis (Melcher et al., 2000; Peters et al., 2001). Specific histone
modifications that characterize PCH, including trimethylated H3K9 and H4K20 and
monomethylated H3K27, were not visibly affected in ATRX-depleted cells (data not
shown).

Trimethylation of Lys9 on histone H3 (H3K9me3) by the Suv39H1

methyltransferase recruits HP1α and forms a compact heterochromatic structure. HP1α
in turn interacts with several chromatin factors, including NIPBL, ATRX and CAF-1
(Lechner et al., 2005). However, we observed that nuclear HP1α as well as HP1β
immunoreactivity was indistinguishable between transiently-depleted and control siRNA
treated cells (Supplementary Figure 2-3), suggesting that ATRX is not required for
proper targeting of these proteins to PCH.
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Figure 2-3. Increased interkinetochore distances and reduced cohesion in ATRXdepleted cells.
(A) ATRX-depleted metaphase cells were stained for the kinetochore proteins CENP-F
or CENP-E (green) in combination with CREST (red) and imaged at different z planes.
Images represent an extended focus rendering of deconvoluted z stacks. (B) Control and
ATRX-depleted cells were stained with anti-CREST antibody to stain kinetochores.
Distances between paired kinetochores (n = 100) were measured at individual z planes
and were significantly increased in shATRX1 and shATRX2 cells compared with control
HG-pSuper cells (P < 0.05 by ANOVA). (C) Mitotic HeLa cells were transiently
transfected with either siATRX-Scr control or siATRX1 and siATRX2 duplexes. After
mitotic shake-off to remove any cells in mitosis, cells were treated with colcemid and
chromosome spreads were stained with DAPI and scored for the percentage of
chromatids displaying cohesion defects (n = 50 per treatment). Chromosomes from
ATRX-depleted cells showed reduced cohesion compared with control scrambled
siRNA-treated cells. (D) Microscopic images of representative chromosome spreads
scored as normal (<10% cohesion defect), moderate (10–90% cohesion defect), or severe
(>90% cohesion defect). Insets show representative chromosomes from each spread with
normal (left), moderate (middle), and severe (right) cohesion defects. Bars: (A and B) 5
µm; (C) 20 µm.
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We next measured the distance between metaphasic sister kinetochores in ATRXdepleted cells using CREST immunostaining.

Sister chromatid inter-kinetochore

distances were significantly increased in both shATRX1 and shATRX2 aligned
metaphases compared to control (HG-pSuper) metaphases (Figure 2-3B; p<0.05
ANOVA).

Increased distance between sister chromatids could reflect a more

decondensed state of chromatin and perhaps fewer nucleosomes associated with centric
chromatin. Alternatively, increased interkinetochore distances could be explained by
reduced cohesion between sister chromatids. We evaluated the extent of cohesion
between the chromatid pairs in DAPI stained metaphase chromosome spreads following
transient depletion using siATRX1 and siATRX2 duplexes in HeLa cells. To rule out
possible effects of extended mitotic arrest (Figure 2-2B), we performed a mitotic shakeoff to remove mitotic cells before colcemid treatment. As a control for non-specific
siRNA effects, cells were transfected with an siATRX1 scrambled duplex.

Mitotic

chromosomes from control metaphase spreads exhibited an association of the
chromosome arms with a primary constriction at the centromeres, resulting in the typical
“X-shaped” chromosomal morphology (Figure 3D, left panel). In contrast, following
transient ATRX interference, we observed a higher proportion of chromosomes that were
separated along the chromosome length with no evidence of primary centromeric
constrictions, indicating reduced centromeric cohesion (Figure 3C). To evaluate the
extent of this defect, chromosome spreads (n=100 per treatment) were categorized as
having a normal (<10%), moderate (10-90%) or severe (>90%) loss of chromatid
cohesion (see examples in Figure 3D). We found that ATRX-depleted cells had a higher
occurrence of spreads displaying cohesion defects compared to the mock-transfected and
non-specific siRNA control (Figure 3C). Severe loss of cohesion (>90% of chromosome
pairs displaying loss of cohesion) was observed at low levels in both controls and
depleted cells (Figure 3C,D), indicating that ATRX depletion results in reduced but not
complete loss of sister chromatin cohesion.
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2.3.5

ATRX Depletion Transiently Activates the Spindle
Checkpoint

The mitotic delay incurred by ATRX depletion prompted us to survey the status of the
spindle checkpoint proteins in ATRX-depleted cells. As such, the pre-anaphase mitotic
delay might result from continued mitotic checkpoint signaling at misaligned
chromosomes. Activation of the spindle checkpoint was confirmed by staining for the
checkpoint proteins BubR1 and Bub1 at misaligned chromosomes. We observed that
both proteins were enriched at a subset of kinetochores in ATRX-depleted metaphases,
with a strong signal at misaligned chromosomes (Figure 2-4A). We further tested the
robustness of the spindle checkpoint by analyzing the fate of cells after exposure to
nocodazole, a microtubule-depolymerizing agent. Nocodazole-induced mitotic arrest was
robust in both control HG-pSuper and ATRX-depleted cells, demonstrating that ATRX is
not required for spindle checkpoint activation (Figure 2-4B). We next selectively
destabilized non-kinetochore fibers by cold treatment. The residual intact kinetochore
fibers (K fibers) were visualized by α-tubulin staining.

We observed that ATRX

depleted cells were characterized by highly irregular arrays of K-fibers (Supplementary
Figure 2-4).

2.3.6

Reduced Levels of ATRX Induce Chromosome Segregation
Defects

Despite the activation of spindle checkpoint proteins, we observed a modest
accumulation of mitotic cells in ATRX-depleted cultures by FACS analysis
(Supplementary Figure 2-2B), suggesting that the checkpoint activation could not be
maintained completely in all cells. As a result, an increased number of cells with lagging
chromosomes at anaphase, telophase, and G1 (Figure 2-4D and Video S2-4) were
observed, indicating a problem with chromosome segregation. A 3 to 7 fold increase in
the number of cells displaying interphase DNA bridges were observed at 48 to 96 hours
post-transfection with ATRX siRNA duplexes compared to control non-targeting siRNA
treated cells (Figure 2-4D and 2-4E).

DNA bridges in mammalian cells produce

micronuclei when the bridges resolve and reform as small membrane bound DNA bodies
(Hoffelder et al., 2004). The number of micronuclei increased 3.4 fold compared to
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Figure 2-4. Spindle checkpoint activation and aberrant chromosome segregation in
ATRX-depleted cells.
(A) The spindle checkpoint protein BubR1 was detected in ATRX-depleted metaphase
cells at both aligned and misaligned chromosomes (top). Another checkpoint protein,
Bub1, was also found to be adjacent to the centromeres (CREST staining) in ATRXdepleted metaphase cells. (B) Mitotic index of control HG-pSuper and ATRX-depleted
cells after 16 h of nocodazole treatment. Control HG-pSuper and ATRX-depleted cells
were cultured with or without nocodazole for 16 h and live cells were photographed and
scored for the percentage of mitotic rounded cells by phase imaging (n > 1,000). (C) Live
cell imaging of control HG-pSuper and ATRX-depleted mitotic cells (n = 100 for each
cell line) revealed an increased number of cells that undergo repeated failed attempts at
initiating anaphase, an increased number of cells that initiate anaphase without full
chromosome alignment, and an increased incidence of segregation defects as indicated by
the formation of chromosome DNA bridges and micronuclei. (D) The number of
internuclear bridges and micronuclei indicative of chromosome missegregation were
quantified at 2–4 d after transfection of the siATRX1 duplex and the fold difference
between mock and depleted cells was calculated. (E) Fixed mitotic cells stained with
DAPI (blue) and a phosphohistone H3S10 antibody (red) showing intranuclear DNA
bridges and micronuclei in transiently depleted cells. Bars in (A) = 5 µm.
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control cells by 96 hours after siRNA treatment (Figure 2-4D). Taken together, these
data suggest that the spindle checkpoint control is compromised in a subset of cells,
causing chromosome segregation errors characterized by lagging chromosomes,
interphase DNA bridges and the subsequent formation of micronuclei.

2.3.7

Defective Mitosis in vivo in ATRX-null Neuroprogenitors

The Cre-mediated deletion of the Atrx gene in the developing mouse forebrain leads to a
reduction in cortical and hippocampal size in newborn pups. In these mice, conditional
deletion of the Atrx gene occurs in nearly 100% of cells in the developing forebrain
starting at approximately embryonic day (E) 8.5 (Bérubé et al., 2005). The analysis of
the mitotic defects by live cell videomicroscopy in ATRX-depleted HeLa cells now
provided indicators of mitotic anomalies that could potentially occur in the Atrx-null
developing mouse brain, and evidence of such abnormalities would indicate that ATRX
contributes to corticogenesis in part by participating in progenitor cell mitosis. The
primary progenitor cells in the developing cortex are the neuroepithelial (NE) cells in the
proliferative ventricular zone (VZ). Due to the fact that cells undergo cyclical migration
within the ventricular zone, mitotic progenitors are always localized at the edge of the VZ
facing the lateral ventricle (LV). Cortical sections from normal embryos at E13.5 were
first examined for the pattern of ATRX protein expression and localization. ATRX
immunoreactivity

was

indeed

enriched

at

condensed

chromatin

of

mitotic

neuroprogenitors lining the lateral ventricle, consistent with a mitotic function (Figure 25A, white arrows).

ATRX was also expressed in cycling cortical progenitors in a

punctate nuclear pattern characteristic of PCH in mouse cells and in differentiated
neurons, as previously reported (McDowell et al., 1999; Bérubé et al., 2005).

To

evaluate the outcome of Atrx loss of function on mitotic cells in vivo during
corticogenesis, brain sections from four different Atrx-null and littermate controls
(Foxg1Cre) were fixed, stained with DAPI to visualize nuclei and chromatin, and the
status of mitotic NE cells lining the ventricular space was evaluated. We observed a high
occurrence of pyknotic nuclei, indicative of cells undergoing apoptosis in the vicinity of
mitotic cells, which confirms previous findings (Bérubé et al., 2005). We also observed a
very high incidence of micronuclei or misaligned chromosomes (Figure 2-5B).
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Figure 2-5. ATRX association with mitotic chromosomes and evidence of mitotic
defects in ATRX-deficient neuroprogenitors in vivo.
(A) ATRX staining of the cortex at E13.5. ATRX is highly expressed in all cells but is
highest in the cortical hem (CH), which gives rise to hippocampal structures. ATRX is
also expressed at increased levels in the differentiated neurons of developing cortical
plate (CP). Mitotic cells that line the lateral ventricle are highly enriched for ATRX
protein (arrows). Higher magnification of the cortical hem (right) demonstrates ATRX
staining of mitotic chromosomes in cells that line the lateral ventricle (arrow). Punctate
nuclear staining of ATRX in cycling cells of the ventricular zone (VZ) is characteristic of
ATRX localization at PCH. (B) Cryosections obtained from Foxg1Cre control and
ATRX-null telencephalon were stained with DAPI to visualize mitotic chromosomes
lining the lateral ventricle (LV) at E13.5. An increased incidence of micronuclei or
dispersed chromosomes was detected in the vicinity of the mitotic layer (arrows) in the
ATRX null embryonic brain. (C) The mean number of micronuclei or dispersed
chromosomes were scored in the mitotic layer from point 1 to 2 as indicated by the white
arrows (top) and are represented in the graph below (n = 4 for each control Foxg1Cre and
ATRX-null brain; P < 0.0001 by nonpaired t test). Error bars represent the standard
deviation of counts from a total of 24 cortical hemispheres from a total of four brains. Cn,
cortical neuroepithelium; Hh, hippocampal hem; Hp, hippocampal primordium. Bars: (A)
100 µm; (B) 40 µm; (C) 200 µm.
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We quantified the occurrence of micronulei/misaligned chromosomes by scoring both
hemispheres in sections from four littermate Atrx-null and control Foxg1Cre embryos and
limited our analysis to the mitotic layer that lines the hippocampal hem, hippocampal
primordium and the dorsal cortical neuroepithelium (Figure 2-5C, between points 1 and
2). This analysis revealed a significant increase in the number of micronulei in Atrx-null
mice compared to Foxg1Cre controls (Figure 2-5C), suggesting that Atrx loss of function
in vivo in mouse neuroprogenitors causes mitotic defects that are similar to that observed
by RNA interference in cultured human cells.

2.4

Discussion

It has been suggested that brain size is partly dictated by the correct expression of genes
that control neuroprogenitor mitosis. Namely, MCPH1 (Alderton et al., 2006; Bartek,
2006), ASPM (Bond et al., 2002; Fish et al., 2006), CDK5RAP2 and CENPJ (Bond et al.,
2005) all have roles in assembling, maintaining and orienting the mitotic spindle, and
mutations of these genes in humans causes primary microcephaly. Our data now suggest
that loss of both ATRX protein isoforms (full-length and truncated form), either by
transient or stable depletion in HeLa cells causes defective sister chromatid cohesion and
chromosome congression at the metaphase plate and that loss of ATRX in the mouse
forebrain also results in mitotic defects. Although ATRX is highly enriched at PCH, we
did not detect abnormal targeting of CENP-E, CENP-F, or HP1α, or in the enrichment of
histone modifications that characterize condensed chromatin at PCH. However, we did
observe a general effect on chromosome condensation in metaphasic chromosomes that
will require further investigation.

Misaligned chromosomes were also observed at

meiosis II upon RNA interference of Atrx expression and by antibody injections in mouse
oocytes (De La Fuente et al., 2004). It is unclear at present whether similar phenomenon
are responsible for the meiotic and mitotic defects, but it is possible that loss of
centromeric cohesion could explain misalignment of chromosomes at meiosis II. Further
investigation of ATRX function on chromatin dynamics and architecture during meiosis
will be required to clarify these issues.
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Several genes involved in chromosome cohesion cause multiple developmental
abnormalities when mutations arise in humans. The best examples to date include the
NIPBL (delangin), SMC1A, and SMC3 genes mutated in Cornelia de Lange syndrome
(CdLS) and the ESCO2 gene mutated in Robert’s syndrome (Krantz et al., 2004; Vega et
al., 2005; Musio et al., 2006; Borck et al., 2007; Deardorff et al., 2007). All of these
factors are components of the cohesin complex or regulators of cohesin loading or
unloading. Syndromes caused by ATRX mutations display partial phenotypic overlap
with

CdLS

syndrome

including

cognitive

delay,

craniofacial

dysmorphisms,

microcephaly, gastrointestinal defects, problems in the genitourinary system, hearing and
ocular development. Another similarity between ATRX and NIPBL is a shared protein
motif that confers the ability to associate with the HP1α chromoshadow domain (CSD)
(Lechner et al., 2005).
ATRX now joins other chromatin remodeling complexes, such as RSC and Snf2h/NURD
implicated in cohesion, either by loading cohesin during DNA replication or by recruiting
the cohesin complex to specific chromosomal regions (Hakimi et al., 2002; Baetz et al.,
2004; Huang et al., 2004). While the cohesin complex is required for normal chromatid
cohesion during mitosis, it also has a function in facilitating long-range enhancerpromoter interactions.

The developmental abnormalities in CdLS and the ATR-X

syndromes could therefore be explained by the specific deregulation of gene expression
at loci that rely on long range enhancer interactions mediated by the cohesin complex and
its regulators. An important focus of research will therefore be to identify such target
genes and determine how chromosome cohesion might control their expression.
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2.5

Supplementary figures

Supplementary Figure 2-1. Validation of ATRX depletion in HeLa cells.
(A) Indirect immunofluorescence detection of the ATRX protein in HeLa cells
transfected with no siRNA (Mock) or with 8nM siATRX1 or siATRX2 siRNA duplexes.
DAPI staining in the lower panels indicates cell confluence at the time of antibody
staining. Bar, 100 µm. (B) ATRX expression was assessed by quantitative RT-PCR using
primers that amplify both ATRX isoforms and the results were normalized to GAPDH
expression. Error bars represent the standard deviation from triplicate samples.
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Supplementary Figure 2-2. ATRX depletion prolongs mitotic duration.
(A) Live cells in culture were followed for 10 h by time-lapse fluorescence microscopy
and the total time from NEBD to G1 reentry was measured for control and ATRXdepleted cells. The error bars represent the SEM from mitoses (n = 50). (B) FACS
analysis of cells stained for DNA content using propidium iodide shows ATRX depletion
does not impact cell cycle progression.
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Supplementary Figure 2-3.
depleted cells.

HP1α and HP1β immunocytochemistry in ATRX-

HeLa cells were transfected with siATRX1 duplex (8 nM) and, 72 h after transfection,
indirect immunofluorescence was performed using the anti-ATRX H-300, anti-HP1α, or
anti-HP1β antibodies, and counterstained with DAPI. HP1α (top) and HP1β (bottom)
proteins are unchanged after transient ATRX depletion when compared with wild-type
untransfected cells. Bar, 20 µm.
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Supplementary Figure 2-4.
depleted cells.

Abnormal mitotic spindle morphology in ATRX-

Control (HG) and ATRX-depleted stable clones (shATRX1 and shATRX2) were coldtreated, fixed, and stained with anti–α-tubulin antibody to reveal kinetochore-bound
microtubule fibers at metaphase (bottom). (top) Endogenous H2B-GFP fluorescence in
these cells. Images represent extended focus of multiple z planes after deconvolution. Bar
= 5 µm.
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Chapter 3

3

Cytokinetic Abnormalities and Multinucleation Induced
by ATRX Depletion

During the course of studying the mitotic cell division in ATRX-depleted HeLa cells, I
consistently observed abnormalities during the terminal stages of cell division, during
anaphase, telophase, and cytokinesis. I decided to more closely examine these stages of
the cell cycle, and to investigate the effect of ATRX depletion on the outcome of a full
cell division cycle. Interestingly, I found that ATRX depleted HeLa cells fail cytokinesis
and produce multinucleated cells at a higher rate than control cells, suggesting an
additional and important consequence of ATRX depletion on mitotic progression and cell
biology.

3.1

Introduction

Cytokinesis is the final stage of the mitotic cell division cycle (M phase), when the newly
generated daughter cells become physically separated following genome replication and
partitioning. This event is achieved through the temporally and spatially co-ordinated
actions of the cell cycle machinery (Wheatley et al., 1997), the cytoskeleton (Rappaport,
1997), and lipid membrane systems (Xu et al., 2002). Cytokinesis is an essential step in
the proliferative program of eukaryotic cells, and is now recognized as a critical process
by which complex organisms are able to achieve their precise morphological fates during
development (Li, 2007). Not surprisingly, cytokinetic regulators are being increasingly
implicated in the aetiology of diverse diseases including short stature (Rauch et al.,
2008), primary microcephaly (Fish et al., 2006; Fu et al., 2007), and cancer (Fu et al.,
2007; Andersen et al., 2007).
Microcephaly is characterized by a reduction of skull circumference and brain volume
resulting primarily from disrupted neuroprogenitor proliferation (Woods et al., 2005) and
survival (Chen et al., 2009) during cortical neurogenesis. Supporting this model, a
number of human genes mutated in primary microcephaly are proposed regulators of cell
division during neurogenesis, including abnormal spindle-like microcephaly-associated
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(ASPM/MCPH5) (Bond et al., 2002), CDK5 regulatory subunit associated protein 2
(CDK5RAP2) (Cox et al., 2006), centromere protein J (CENPJ) (Bond et al., 2005), and
pericentrin (Rauch et al., 2008).

In addition, genes that specifically regulate

neuroprogenitor cytokinesis in murine models have been implicated in achieving normal
brain size, including the Rho-effector Citron Kinase (Di Cunto et al., 2000; LoTurco et
al., 2003).
ATRX is a SWI/SNF chromatin remodelling protein required for the early development
of several organs, particularly the central nervous system (CNS). In humans, ATRX gene
mutations cause α-thalassemia/mental retardation X-linked (ATR-X) syndrome,
characterized by postnatal microcephaly, severe cognitive and behavioural deficits, and
skeletal and urogenital abnormalities. Affected patients also often display α-thalassemia
caused by decreased levels of α-globin (Gibbons et al., 1995; Gibbons, 2006). ATRX
mutant alleles have been identified in other X-linked mental retardations (XLMRs),
including Carpenter-Waziri (Abidi et al., 1999), Juberg-Marsidi (Villard et al., 1996),
Holmes-Gang (Stevenson et al., 2000), Smith-Fineman-Myers (Villard et al., 2000), and
Chudley-Lowry syndromes (Abidi et al., 2005). In the mouse, Atrx loss of function from
the 8- to 16-cell stage is lethal at embryonic day 9.5 (E9.5) due to defective formation of
the extraembryonic trophoblast (Garrick et al., 2006). Targeted disruption of the fulllength ATRX isoform in the mouse forebrain from E8.5 results in decreased forebrain
size and elevated neuronal cell death, suggesting a role for ATRX in cortical expansion,
and neuronal survival (Bérubé et al., 2005). ATRX deficiency is therefore detrimental to
both mouse and human development, indicating a requirement for ATRX in basic cellular
functions.
Although ATRX has been proposed to primarily regulate gene transcription, the protein
is enriched at pericentromeric heterochromatin (McDowell et al., 1999), and appears
hyperphosphorylated and highly enriched at condensed chromosomes during mitosis in
human cells, suggesting an additional function during this stage of the cell cycle (Bérubé
et al., 2000). ATRX is required for chromosome alignment on the metaphase II meiotic
spindle in mouse oocytes (De La Fuente et al., 2004), and more recently we have shown a
requirement for ATRX in mitotic chromosome congression, alignment, and cohesion in
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human cells (Ritchie et al., 2008). We now extend our previous studies and report
defects in the progression of cytokinetic events upon depletion of ATRX in HeLa cells.
We show that RNAi-mediated depletion of ATRX results in an increased proportion of
polynucleated cells and prolonged cytokinetic duration accompanied by morphological
abnormalities of the cell membrane. These results show that ATRX loss of function can
impede the cytokinesis process, either indirectly due to abnormal chromosome
segregation, or directly by a yet unknown mechanism. Cytokinetic failure might provide
an explanation for the increased cell death and size reduction observed in the ATRX-null
mouse forebrain and some of the developmental abnormalities that characterize ATR-X
patients.

3.2
3.2.1

Materials and Methods
Cell Culture and Generation of Stable Clones

All cell lines were grown in a humidified environment at 37 °C and 5 % CO2. HeLa cells
were grown in DME (Sigma) supplemented with 10 % FBS (Gibco). HeLa-HG cells
were grown in DME supplemented with 10% FBS and 2 µg/ml Blasticidin S-HCl
(Gibco) to maintain transgene expression. HeLa-HG-sh1 cells were grown in DME
supplemented with 10% FBS and 2 µg/ml Blasticidin S-HCl and with 400 µg/ml
G418/Geneticin (Invitrogen) to maintain short-hairpin RNA (shRNA) expression. Stable
HeLa-HG clones expressing shRNA corresponding to the siATRX1 sequence (HeLaHG-sh1) were generated and validated as described in (Ritchie et al., 2008). Briefly,
pairs of sense 60-mer oligonucleotides corresponding to the 19-mer siATRX1 siRNA
target sequences and their reverse complement (underlined sequences) were designed that
contained 5’ BglII and 3’ HindIII restriction sites (Integrated DNA Technologies, Inc.) to
facilitate cloning into the pSuper.retro.neo plasmid vector (Oligoengine Inc.): shATRX1
(sense) 5’-GATCCCCGAGGAAACCTTCAATTGTATTCAAGAGATACAATTGAAG
GTTTCCTCTTTTTA-3’. The oligonucleotides were annealed to complementary antisense 60-mer oligonucleotides in buffer containing 10 mM Tris pH 7.5, 50 mM NaCl,
and 1 mM EDTA at 90ºC for 4 min, followed by 70 ºC for 10 min, then step cooled to 37
ºC for 20 min using a thermocycler (MJ research) and cloned into the pSuper.retro.neo
plasmid (Oligoengine Inc.) using the Quick Ligation Kit according to manufacturer’s
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instructions (New England Biolabs).

The resulting vector construct, designated

pSUPER-shATRX1, was subsequently sequenced to confirm sequence identity.
Exponentially growing HeLa-H2B-GFP were transfected with empty pSuper vector or
with pSuper-shATRX1 vector (1 µg/ml) using Lipofectamine 2000 (Invitrogen). Two
days after transfection, cells were re-plated at low density and selection was applied 24
hours later (800 µg/ml Geneticin, Invitrogen). Drug-resistant colonies were picked and
expanded in selection media (400 µg/ml Geneticin).

3.2.2

RNA Interference, Immunostaining and Microscopy

All siRNA transfections were conducted using 8nM siRNA and the cationic lipid reagent
Lipofectamine 2000 (Invitrogen) according to manufacturer’s instructions. The synthetic
RNA oligonucleotides siATRX1 (5’-GAGGAAACCUUCAAUUGUAUU-3’) was
obtained from Dharmacon (Lafayette, CO). Control (non-targeting) duplex was obtained
from Sigma Aldrich. Mock-transfected samples were treated similarly but without the
addition of siRNA to the transfection mixture. For immunofluorescence experiments,
cells were grown on 22 mm2 glass coverslips (VWR Inc.) and fixed using ice cold 3:1
EtOH:MeOH up to 4 days following plating or 3 days following siRNA/mock
transfection. Following fixation, coverslips were incubated with sequential dilutions of
primary followed by fluorophore-conjugated secondary antibodies diluted in PBS + 0.3%
TX-100. Primary antibodies used: rabbit anti-ATRX H300 (Santa Cruz Biotech, 1:200),
mouse-anti-α-Tubulin (Sigma-Aldrich, 1:1000), mouse-anti-Plk1 (Upstate, 1:200),
mouse-anti-Myosin II (Upstate, 1:200). Secondary antibodies used: Alexa Fluor 594 goat
anti-mouse IgG, Alexa Fluor 488 goat anti-mouse IgG, Alexa Fluor 594 goat anti-rabbit
IgG, and Alexa Fluor 488 goat anti-rabbit-IgG (Invitrogen, 1:1500). The DNA dye DAPI
was used as a nuclear counterstain. Coverslips were mounted using Vectashield H-1000
antifade solution (Vector Labs). Imaging was performed using a DMI 6000b inverted
microscope (Leica) and digital camera (ORCA ER; Hamamatsu). Image acquisition was
performed using a Power Mac G5 computer (Apple Inc.) and Openlab imaging software
(v5.0, Perkin-Elmer). Image analysis was performed using Volocity imaging software
(v4.0, Perkin-Elmer) and Adobe Photoshop (vCS4, Adobe).
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3.2.3

Live-Cell Video-Microscopy

HeLa-HG or HG-shATRX1 cells were grown in 35 mm dishes (Corning). Following a
24 hour incubation in a tissue culture incubator at 37°C and 5 % CO2, growth media was
replaced with CO2 independent media (Gibco) supplemented with 10% FBS (Sigma) and
4mM L-Glutamine (Gibco). The culture dish was mounted on an inverted microscope
(DMI 6000b; Leica) and maintained at 37°C using a Livecell incubator (Neue
Biosciences). Phase-contrast and fluorescence images were captured at intervals between
2 and 10 minutes for up to 48 hours using the automation feature of Openlab and
analyzed using Volocity. To measure cytokinetic duration, cells (N=100) were measured
from anaphase onset (AO), characterized by the visible cytokinetic cleavage furrow and
initiation of chromatid segregation, until the end of telophase, characterized by nuclear
decondensation and cytoplasmic expansion.

3.3
3.3.1

Results
ATRX Depletion Causes Multinucleation

Actively growing HeLa cells were treated with a small interfering RNA (siATRX1) that
specifically targets full-length ATRX transcripts. We have previously shown that RNA
interference under these conditions results in substantial depletion of both ATRX mRNA
and protein (Ritchie et al., 2008). Following transfection, staining for the microtubule
protein α-tubulin revealed an increased number of cells connected to each other by
cytoplasmic microtubule bridges at the cytokinetic midzone (Figure 1A, asterisk).
Spindle midzone formation in ATRX depleted cells often appeared bent or narrow, while
only minor variability in organization was observed in control cells expressing normal
levels of ATRX (see example Fig 3-1A, asterisk). We also observed increased number of
cells with more than one nucleus or with multilobular nuclei (Figure 3-1A, arrowheads).
This phenotype was quantified and revealed a 3- to 4-fold increase in the number of bi- or
multinucleated cells in HeLa cells transiently depleted of ATRX at 24 hours following
siRNA transfection, and this effect persisted until at least 96 hours post transfection
(Figure 3-1B).
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Figure 3-1. Transient ATRX depletion causes cellular multinucleation.
(A) HeLa cells were depleted of ATRX using transient siRNA (siATRX1) transfection,
or mock transfected with Lipofectamine only (Mock). Immunostaining with anti-ATRX
antibody confirmed ATRX depletion in the majority of cells treated with siATRX1
duplex. (B) Cells were immunostained with anti-α-tubulin antibody and the nuclear
counterstain DAPI 48 hours following transfection. Cells treated with siATRX1 had a
higher frequency of multinucleation (asterisk), lobulated nuclei (arrows), and nuclear
holes (chevron) than controls. (C) Multinucleation was quantified in mock-treated and
siATRX1-treated cells every 24 hours following siRNA transfection, up to 96 hours (n >
300 cells at each time point). Cells treated with siATRX1 showed increased levels of
multinucleation at all time points examined following treatment.
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3.3.2

ATRX-Depleted Cells Take Longer to Progress from
Anaphase to G1

Increased levels of multinucleation in ATRX-depleted cells suggested that many cells fail
to undergo cytokinesis following mitosis. To investigate the role of ATRX during cell
cycle progression in live cells, we utilized HeLa cells that express Histone 2B fused with
the green fluorescent protein (HeLa-HG cells). Using a combination of phase contrast
and fluorescence microscopy, we were able to follow mitotic events in actively dividing
HeLa-HG cells using time-lapse imaging. Stable ATRX depletion was achieved by
generating a HeLa-HG clone (HG-shATRX1) that constitutively expresses a short hairpin
RNA (shRNA) targeting the full length ATRX mRNA, yielding very good reduction of
ATRX protein levels, as previously described (Ritchie et al., 2008). Using time-lapse
microscopy, we measured the amount of time required for the mitotic cells to proceed
from anaphase onset (first imaging frame with evidence of chromatid segregation) to reentry into G1 (time of complete nuclear decondensation) (Figure 3-2A). This analysis
demonstrated that the duration of anaphase to G1 transition was more than doubled in
ATRX depleted HG-shATRX1 compared to wild type cells (N=100, p<0.0001, t-test),
with an average of 74.1 min and 36.0 min, respectively (Figure 3-2A,B and Video S3-1 HeLa-HG Normal Cytokinesis and additional file 2: Video S3-2 - HG-shATRX1
Membrane Instability).

3.3.3

Increased Cytokinetic Failure in ATRX-deficient Cells

The increased time required to reach G1 following chromosome segregation, as well as
the higher levels of multinucleation, suggested that the process of cytokinesis might be
disrupted in ATRX-depleted cells. We thus examined the cellular events of cytokinesis,
including anaphase and telophase, and observed morphological abnormalities during the
telophase and cytokinetic phases in ATRX-depleted cells. Cells lacking ATRX exhibited
a high frequency of spontaneous disorganization of the lipid membrane. Immediately
following ingression of the cleavage furrow during anaphase, the cell membrane
frequently appeared disorganized and highly unstable (Figure 3-2A,C and additional file
2: Video S3-2 - HG-shATRX1 Membrane Instability).

Plasma membrane

disorganization was seen in 6.0% of control mitotic cells, but increased to 19.0% of
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Figure 3-2. ATRX depletion causes delayed progression from anaphase to G1.
(A) Actively growing control (HG) cells and ATRX-depleted (HG-sh1) HeLa cells were
visualized using time-lapse microscopy with a combination of phase and fluorescence
microscopy from the onset of anaphase (AO, Time = 0 min) to G1 re-entry (nuclear
decondensation, last frame shown in sequence). ATRX-depleted HG-sh1 cells were often
delayed in reaching G1 phase after anaphase onset relative to control cells. (B)
Cytokinetic duration was measured from time-lapse live-cell videomicroscopy
experiments of control HG or ATRX-depleted HG-sh1 cells (n = 100), and was found to
be significantly increased in HG-sh1 cells (p < 0.0001, t-test). (C) Membrane instability,
defined as membrane blebbing between anaphase onset and the completion of cytokinesis
(see panel A, HG-sh1), was found to be increased (p < 0.05, Yates’ χ2 test) in ATRXdepleted HG-sh1 cells (6%, N = 100) compared to controls (HG) (19%, N=100). Bar in
(A) = 16 µm.
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HG-shATRX1 mitotic cells (N=100, Figure 3-2C). In addition, we observed that ATRX
depleted cells failed the terminal stages of cytokinesis and produced binucleated cells
(Figure 3-3, additional file 3: Video S3-3 - HG-shATRX1 Failed Cytokinesis).
Cytokinetic failure occurred in 5% of control HeLa-HG cells, and more than doubled to
11% of HG-shATRX1 cells (Figure 3-3B). We followed these binucleated cells using
live-cell time-lapse video microscopy, and found that they often underwent programmed
cell death several hours later (Figure 3-4, additional file 4: Video S3-4 - HG-shATRX1
Binucleate Cell Death).

3.3.4

Normal Midbody Organization in ATRX-depleted Cells

To determine if the observed cytokinetic defects were due to disruption of the midzone
spindle or cytokinetic midbody, mock and siATRX1 treated cells were stained with an
antibody against Polo-like kinase 1 (Plk1). Plk1 is normally localized to the midzone and
midbody, where it phosphorylates a number of substrates, including kinesin (MKLP2)
and dynein (NudC) subunits and is required for normal cytokinetic progression and
termination. Plk1 localized to the midzone and midbody normally in ATRX-depleted
cells, suggesting that the integrity of the central spindle and the associated Plk1dependent signaling pathway is intact (Figure 3-5).

3.3.5

Relationship Between Cytokinetic Abnormalities and
Chromosome Bridging

We have previously reported that ATRX depletion in HeLa cells causes chromosome
congression, cohesion, and segregation defects during mitosis (Ritchie et al., 2008). It
was therefore possible that chromosomal bridges are impeding cytokinetic progress in
ATRX-depleted HeLa cells. To investigate this possibility, we conducted time-course
live-cell microscopy of actively dividing HG and HG-sh1 cells, measured the number of
mitotic cells that failed cytokinesis and determined whether this defect was preceded by
the appearance of a chromosome bridge. We found that distinct chromosome bridges
during anaphase and telophase often preceded cytokinetic failure and binucleation in
ATRX depleted cells. Of 70 HG-sh1 cells that underwent cytokinesis, 11 were seen to
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Figure 3-3. ATRX depleted cells show elevated levels of cytokinetic failure.
(A) ATRX-depleted (HG-sh1) cells more often failed cytokinesis (arrows, lower panel)
than control (HG) cells. Cytokinetic failure was measured from time-lapse live-cell
video microscopy and was defined as the generation of bi-nucleated cells following the
end of M phase (asterisk, lower panel). Numbers indicate time in minutes following the
first frame (Time = 0). (B) Successful completion or failure of cytokinesis was scored
using time-lapse live-cell video microscopy. ATRX-depleted cells failed cytokinesis
more often than control HG cells (11% vs. 5% of observed cytokinetic events
respectively, n = 100 per genotype, not statistically significant). Bar in (A) = 16 µm.
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Figure 3-4. Cell death following cytokinetic failure and multinucleation.
Selected captured images from time-lapse videomicroscopy of ATRX depleted HGshATRX1 cells. The arrow indicates a cell that failed cytokinesis and became
multinucleated, and then underwent cell death. Numbers indicate time in minutes
following the first frame (0 min). Bar = 16µm.
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produce binucleated progeny, 8 (73%) of which were associated with the appearance of a
chromosome bridge during anaphase, telophase, or cytokinesis. Notably, no apparent
chromosomal abnormalities could be identified during cytokinesis in approximately 27%
of the mitotic cells that failed cytokinesis. These results suggest that that failure to
complete cytokinesis is often a consequence of chromosome bridges, possibly caused by
ATRX dependent chromosome alignment and segregation, but that some cytokinetic
abnormalities might result from alternative mechanisms.

3.4

Discussion

Our data demonstrate that decreased levels of ATRX can often result in cytokinetic
defects or even failure. We used live cell microscopy to show that ATRX depletion
causes a delay at the end of mitosis and during cytokinesis, morphological abnormalities
of the plasma membrane, and cytokinetic failure. Our recent report that ATRX plays a
critical role during mitosis in human cells suggests that altered chromatid cohesion and
segregation in ATRX-deficient cells may indirectly impact normal cytokinetic progress
(Ritchie et al., 2008).

DNA bridges and poorly resolved chromatin masses pose a

physical barrier to cytokinesis (Cutts et al., 1999), whereby the cell actively halts
cytokinesis to prevent physical damage to its own genome. Notably, many ATRXdepleted cells displaying cytokinetic failure were accompanied by chromosome
segregation defects, suggesting that the observed phenotypes may be dependent on
chromosomal nondisjunction. Furthermore, the cytokinetic midzone and midbody are
properly enriched for Plk1 in ATRX-depleted cells, suggesting that the cytokinetic
abnormalities do not reflect a defect in general functional composition of the midzone or
midbody. Regulatory proteins have now been identified that integrate early mitotic
events with cytokinesis. Named the chromosome passenger complex (CPC) by virtue of
its dynamic localization during M-phase, the core CPC complex is comprised of inner
centromeric protein (INCENP), aurora B kinase, survivin, and borealin (Ruchaud et al.,
2007). The CPC proteins are centromeric during early stages of M phase where they play
an essential role in chromosome alignment (Mackay et al., 1998; Gassmann et al., 2004;
Vong et al., 2005), but are shuttled to the spindle midzone and equatorial cell cortex upon
anaphase commitment where they stabilize the central spindle and are essential
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Figure 3-5. Plk1 normally localizes to the spindle midzone and midbody in ATRXdepleted cells.
HeLa cells were depleted of ATRX using transient RNAi (siATRX). After 72h, protein
knockdown was confirmed using ATRX immunostaining. Cells were stained with an
antibody against PLK1 (green). Different stages of the cell cycle were determined based
on the pattern of Plk1 staining at the midzone (Anaphase) or midbody
(Telophase/Cytokinesis).
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for cytokinesis (Ruchaud et al., 2007). Other kinetochore-associated proteins have been
implicated in both mitotic chromosome alignment and cytokinesis, including the DNA
binding protein CENP-C (Kwon et al., 2007), the kinetochore motor protein CENP-E
(Liu et al., 2006), and the large coiled-coil protein CENP-F/Mitosin (Holt et al., 2005).
These examples demonstrate the relationship between centromeric proteins and
cytokinesis, which may describe a novel function of the ATRX protein
Cytokinetic abnormalities caused by Citron kinase deficiency in the mouse brain result in
strikingly similar morphological defects seen in the Atrx-null brain (Bérubé et al., 2005),
including smaller forebrain (especially in the caudal areas), normal proliferation but
increased cell death, and decreased numbers of superficial layer neurones (Di Cunto et
al., 2000). ATRX is highly expressed in the neuroepithelial cells lining the lateral
ventricles of the embryonic mouse forebrain. Based on the data presented in the present
report, we speculate that ATRX could play a role during cytokinesis during
neuroprogenitor proliferation.

Loss of ATRX in the embryonic forebrain of the

conditional knockout mouse may disrupt the proliferative divisions of the
neuroprogenitor cells, depleting the pool of neuroprogenitors required for subsequent
cortical expansion. These results provide a functional link between ATRX-dependent
cell division and the cortical defects observed in the ATRX-null mouse forebrain.
In addition to a broad spectrum of developmental consequences, mitotic defects can be
associated with oncogenic events and tumorigenesis due to genomic instability
(Montgomery et al., 2003). To date there is no evidence that ATR-X patients exhibit
mitotic defects or are prone to developing cancer, however there is increasing evidence
for a role of ATRX in neoplasia outside of the context of ATR-X syndrome (Steensma et
al., 2004). Recently, ATRX was found to be mutated in a large proportion of pancreatic
neuroendocrine tumours (PanNETS), suggesting that it might have tumour suppressive
functions (Jiao et al., 2011). All ATRX mutations correlated with loss of immunolabeling
in these hyperplastic pancreatic islet cells, suggesting that complete loss of ATRX protein
is associated with oncogenetic events in PanNETs. Furthermore, another recent study of
PanNETs found substantial chromosomal alterations in 98% of samples (Hu et al.,
2010), suggesting that genomic instability could contribute to PanNET oncogenesis.
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Together these data suggest that ATRX might be a novel tumor suppressor gene, possibly
through maintaining the accuracy of chromosome segregation during mitosis.

3.5
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Chapter 4

4

ATRX Regulates Cortical Development Through Control
of Neural Progenitor Cell Division

Mitotic cell division is considered one of the primary mechanisms used by neural
progenitor cells to initiate the neuronal/glial fate commitment. Studies of the Atrx-null
mouse cortex had previously identified cortical defects, including a reduction in the
volume of the forebrain, and reduction in the radial and tangential dimensions of the
cortex, suggesting a broad neurodevelopmental defect. This phenotype is similar to those
observed in rodent models deficient for other genes involved in neural progenitor cell
division (Cit){LoTurco 2003; Di Cunto 2000;Chang 2010}. Importantly, disruption of
neural progenitor cell division can lead to changes in the regulation of neuron production,
and lead to altered patterns of cortical layering and imbalances in the proportions of
different neuronal layers, something that had not yet been investigated in the Atrx-null
mouse.

4.1

Introduction

Inherited mutations of the ATRX gene, encoding the SWI/SNF2 family chromatin
remodeling protein ATRX, are associated with a spectrum of syndromic and nonsyndromic mental retardations characterized by developmental delay, cognitive deficits
and microcephaly (Gibbons, 2006). ATRX utilizes the energy of ATP hydrolysis to
disrupt histone-DNA interactions, and has strong DNA translocase activity (Xue et al.,
2003), suggesting a role for ATRX in chromatin remodeling and regulation of gene
transcription. Supporting this, ATRX has been shown to regulate the expression of a
number of imprinted target genes in the mouse brain (Kernohan et al., 2010), to bind
tandem repetitive DNA elements in telomeric and euchromatic regions as a means to
regulate gene expression (Law et al., 2010), and to deposit the histone variant H3.3 at
telomeric and pericentric heterochromatin in cooperation with the histone chaperone
Daxx (Goldberg et al., 2010; Drané et al., 2010; Lewis et al., 2010). ATRX is highly
enriched at pericentromeric heterochromatin in mouse and human cells throughout the
cell cycle (McDowell et al., 1999) where it becomes hyperphosphorylated at the onset of
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the mitotic phase (Bérubé et al., 2000), and is required for normal chromosome alignment
during both mitosis and meiosis (De La Fuente et al., 2004; Ritchie et al., 2008; Baumann
et al., 2010). Conditional inactivation of Atrx in the developing mouse forebrain prior to
the onset of neurogenesis leads to reduced forebrain size, hippocampal dysgenesis, and
elevated p53-dependent neuronal apoptosis (Bérubé et al., 2005; Seah et al., 2008).
Inactivation of p53 leads only to a partial rescue of cortical size, indicating that additional
mechanisms contribute to the Atrx-dependent cortical phenotype in this model (Seah et
al., 2008).
The mature mammalian cerebral cortex is laminated into six stratified layers, each
populated by distinct neuronal subtypes with unique cell morphologies, gene expression
profiles, and neuronal connectivites (Campbell, 2005).

Excitatory glutamatergic

projection neurons constitute the large majority of cortical neurons, and are produced by
apical and basal neural progenitor cells (NPCs) in the germinal ventricular and
subventricular zones, respectively, adjacent to the lateral ventricles in the dorsal
telencephalon (Gorski et al., 2002; Noctor et al., 2004). In the mouse, cortical
development is characterized by an initial expansion of the neural progenitor cell
population through symmetric proliferative cell divisions, followed by a transition to
asymmetric neurogenic cell divisions at embryonic day (E) 14 (McConnell, 1995). These
new neurons migrate radially away from the lateral ventricle along a scaffold of radial
glia projections to their final cortical destinations in a temporally determined inside-out
fashion, with the earliest born neurons populating the deep cortical layers (V-VI), and
late born neurons found in the superficial layers (II-IV) (Rakic, 1974). Throughout
cortical neurogenesis the appropriate balance of neural progenitor self-renewal,
differentiation, and survival is required to achieve proper cortical size and functional
organization (Rakic, 1995; Haydar et al., 1999; Kriegstein et al., 2006). Ultimately, the
fate of a daughter cell born from a dividing apical NP depends in part upon the
inheritance of the relatively small apical membrane and its associated factors, including
m-Numb (Petersen et al., 2002; Shen et al., 2002; Petersen et al., 2004) and Par-3
(Kosodo et al., 2004; Bultje et al., 2009), which likely specify cell fate through the notch
signaling pathway. Inheritance of the apical domain by the two daughter cells during
symmetric cell division yields two NPCs, resulting in a proliferative expansion of the
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progenitor pool during the early stages of neurogenesis. Conversely, inheritance of the
apical domain by only one daughter cell during asymmetric cell division leads to the
differentiation of the daughter cell lacking the apical domain.

Certain proteins

implicated in cortical development and microcephaly have been shown to regulate the
orientation of the mitotic spindle during apical neural progenitor mitosis (Woods et al.,
2005), including ASPM (Fish et al., 2006), and CDK5RAP2 (Lizarraga et al., 2010). In
these cases it is thought that disrupted mitotic spindle and cleavage plane orientation
increases the proportion of asymmetric NPC divisions, prematurely depleting the NPC
pool and leading to a loss of late-born neurons and a smaller cortex.
In the present report, we show that isolated Atrx-null neuroprogenitors display mitotic
chromosome misalignment and missegregation phenotypes similar to those observed in
an ATRX depleted human somatic cell line (Ritchie et al., 2008). Dividing apical neural
progenitors in the Atrx-null embryonic forebrain are more often seen in an asymmetric
orientation, suggesting that the absence of ATRX might affect the timing and balance of
apical progenitor cell differentiation. Indeed, we observed an overproduction of Tbr1
expressing layer VI neurons in the postnatal Atrx-null cortex, and fewer Brn2 expressing
neurons in the superficial cortical layers. Furthermore, the NPC pool was reduced in the
late-stage Atrx-null forebrain. We propose that loss of Atrx early in neurogenesis disrupts
the ability of apical progenitor cells to maintain the highly regulated symmetric
orientation of the mitotic spindle, possibly due to failed mitotic chromosome alignment
and segregation, consequently disrupting the balance of progenitor cell proliferation and
neuronal differentiation, and ultimately leading to abnormal cortical architecture.

4.2 Materials and Methods
4.2.1

Animal Husbandry

Conditional deletion of Atrx in the mouse forebrain was achieved by crossing AtrxloxP
females with heterozygous Foxg1Cre knock-in males, as previously described (Bérubé et
al., 2005; Ritchie et al., 2008; Seah et al., 2008). The AtrxloxP line was kindly provided by
D. Higgs and R.J. Gibbons (Weatherall Institute of Molecular Medicine, John Radcliffe
Hospital, Oxford, United Kingdom). For embryonic studies, vaginal plugs were checked
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at 9 am and midday of positive plugs were considered E0.5. All animal studies were
conducted in compliance with the regulations of The Animals for Research Act of the
province of Ontario, the guidelines of the Canadian Council on Animal Care, and the
policies and procedures approved by the University of Western Ontario Council on
Animal Care.

4.2.2

Western Blot Analysis

Protein was extracted from mouse forebrain cortical tissues of Atrx-null (Atrxf/y Foxg1Cre)
and control (Atrxwt/y Foxg1Cre) littermates at P7 and P10 using RIPA buffer (150 mM
NaCl, 1 % NP-40, 50 mM Tris, pH 8.0, 0.5 % deoxycholic acid, 0.1 % SDS, 0.2 mM
PMSF, 0.5 mM NaF, 0.1 mM Na3VO4, and 1 % protease inhibitor cocktail tablet
[Complete mini, EDTA-free; Roche]) for 30 minutes on ice (for Tbr1 and Ctip2), or
using the NE-PER nuclear and cytoplasmic protein extraction kit (for Brn2) (Thermo
Scientific) and protein concentration was quantified from 280 nm absorbance
measurements using a NanoDrop ND-1000 Spectrophotometer (Thermo Scientific).
Isolated total protein (10-30 µg) was resolved using 8 % SDS-PAGE and transferred onto
nitrocellulose membranes (Bio-Rad Laboratories). The membranes were probed with
goat anti-Brn2 (1:1000, Santa Cruz Biotechnology, Inc.), rabbit anti-Tbr1 (1:1000,
Abcam), and rabbit anti-Ctip2 (1:1000, Abcam) followed by the appropriate horseradish
peroxidase (HRP)–conjugated secondary antibody (1:5,000; GE Healthcare).

The

membranes were incubated in enhanced chemiluminescence reagent (ECL) before
exposure to x-ray film (Amersham). The membranes were reprobed with mouse anti-αtubulin (1:40,000; Sigma-Aldrich) or anti-INCENP as a loading control. Band intensities
were quantified from developed film using a Fluorchem 8800 gel documentation system
(Alpha Innotech Corp., San Leandro, CA)

4.2.3

Neuroprogenitor Cultures

Embryos were isolated at E13.5 days of gestation, measured after the observation of a
mating plug (E0.5). Pregnant dams were euthanized by CO2 asphyxiation. Embryonic
cortices were dissected into ice-cold Hank’s Balanced Salt Solution (HBSS, Sigma),
dissociated by trituration and plated in Neurobasal media (Gibco) supplemented with 1 %
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Penicillin-Streptomycin, 1 % Glutamax (Gibco), 1 % N2 supplement, and 25 ng/ml bFGF
in 4-well plates (Nunc).

Cultures were maintained in a humidified tissue culture

incubator at 37 °C and 5 % CO2.

4.2.4

Cryosectioning

For embryonic time points, whole mouse embryos were collected from CO2 euthanized
pregnant dams at specific gestational ages (E13.5, E16.5) and stored in phosphate
buffered saline (PBS) pH 7.4 with 4 % paraformaldehyde (PFA) at 4 °C for 16-24 hours.
For postnatal day P7, mice were lethally sedated with CO2 and were transcardially
perfused with 4 % PFA-PBS pH 7.4. Brains were then dissected and stored in 4 % PFAPBS pH 7.4 at 4 °C for 16-24 hours. Samples were cryoprotected in 10-30 % sucrosePBS pH 7.4, embedded in Shandon Cryomatrix (Thermo Scientific), sectioned using a
Leica cryostat (CM 3050S), and collected on Superfrost+ glass microscope slides
(VWR).

4.2.5

Immunofluorescence Staining and Quantification

Prior to immunostaining, tissue cryosections were heated for 10 minutes in 10 mM NaCitrate (pH 6.0) in a microwave to unmask antibody binding-sites. Cryosections were
incubated with primary antibodies diluted in PBS + 0.3 % Triton X-100 overnight at 4 °C
in a Shandon Sequenza slide rack (Thermo), rinsed in PBS, incubated with secondary
antibodies diluted in PBS + 0.3 % Triton X-100 for 1 hour, followed by a 5 minute
incubation with DAPI (1 µg/ml in PBS, Sigma) as a nuclear counterstain, rinsed with
PBS and mounted in SlowFade Gold (Invitrogen) or Vectashield H-1000 (Vector Labs)
fluorescent mounting media. Antibodies used were anti-γ-Tubulin, anti-Ctip2 (1:500,
Abcam), anti-Tbr1 (1:200, Abcam), anti-Brn2 (1:50, Santa Cruz), anti-Tbr2 (1:500,
Abcam), anti-Pax6 (1:50, Santa Cruz). Immunofluorescence images were captured using
a Leica DMI-6000B inverted microscope (Leica Microsystems) equipped with a digital
camera (ORCA-ER, Hammamatsu). Image capture was achieved using Openlab v5.0
(Perkin Elmer) and processed using Volocity v5.4 (Perkin Elmer) and Photoshop CS3
(Adobe). To analyze P7 cortical layer thickness, three different measurements separated
by 100 µm were made perpendicular to the lateral cortical axis in equivalent regions from
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three sequential cryosections per brain from n = 5 mice for both control and Atrx-null
samples. For P7 cortical cell quantifications, 200 µm-wide columns perpendicular to the
lateral cortical axis were quantified for specific immunopositive cells in equivalent areas
from 3 adjacent cryosections per brain from n = 5 mice for control and Atrx-null samples.
Statistical analysis of the sample means was performed using student’s t-test.

For

neuroprogenitor mitotic figure analysis, cultures were fixed with 2 % PFA in PBS pH 7.4
after 2-3 days in culture, immunostained with anti-Atrx (Santa Cruz) and counterstained
with DAPI (1 µg/ml in PBS), and mounted in Vectashield H-1000 mounting media
(Vector labs). Cells were quantified from n = 3 mice for control and n = 4 for Atrx-null.

4.3
4.3.1

Results
Abnormal Chromosome Alignment and Segregation in
Cultured Atrx-null Neuroprogenitors

A mouse model of Cre-mediated Atrx inactivation in the developing embryonic mouse
forebrain has been previously described (Bérubé et al., 2005) (AtrxFoxg1Cre mice, defined
as Atrx-null hereafter). In this model, Atrx is inactivated in cortical NPCs at age E8.5,
prior to the onset of neurogenesis, resulting in loss of Atrx expression in all cortical
neurons. The Atrx-null forebrain is reduced in size at birth, with elevated P53-dependent
cortical cell death (Bérubé et al., 2005; Seah et al., 2008). We have previously reported
that the Atrx-null embryonic forebrain displays dispersed chromatin fragments in close
association with the mitotic NPCs of the ventricular zone lining the embryonic lateral
ventricles (Ritchie et al., 2008). To determine whether this phenotype reflects disrupted
mitotic chromosome alignment in the NPCs of the developing neuroepithelium, we
established primary cell cultures of control and Atrx-null NPCs isolated from E13.5
telencephalon. Isolated cells were cultured in Neurobasal media supplemented with N2
and bFGF to allow for colony growth of dividing NPCs, and the cultures were fixed and
stained with DAPI two days after plating.

Mitotic figures were identified by

characteristic condensed chromatin morphologies, and scored for evidence of
abnormalities. We found that embryonic NPCs isolated from Atrx-null cortices were
more often seen with abnormal mitotic figures, including misaligned chromosomes
during metaphase and chromatin bridges during anaphase/telophase (Control = 10/161
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(6.21%), Atrx-null = 23/114 (20.18%)) (Figure 4-1A, B). These results indicate that Atrx
is required for proper chromosome dynamics during mitotic cell division of cortical
NPCs.

4.3.2

Disrupted Angle of Division in Atrx-null Apical
Neuroprogenitors Lining the Ventricular Zone

Normal neocortical development relies on the temporally choreographed balance of
progenitor cell divisions.

Initially the progenitor population is expanded through

symmetric proliferative cell divisions, which is then followed by a shift to asymmetric
differentiative divisions that yield the variety of cell types found in the mature cortex.
The balance and timing of these two modes of division are critical to achieve normal
cortical size and patterning (Kriegstein et al., 2006). The differential inheritance of the
apical plasma membrane is considered a key determinant in the ultimate fate decision of
daughter neuroprogenitor cells.

This mechanism is achieved by controlling the

orientation of the mitotic spindle and cytokinetic cleavage furrow to orient that axis of
cell division relative to the apical cell surface. Disruption of spindle orientation or
cleavage angle has been linked to microcephalic phenotypes in murine models. To assess
whether ATRX is required to achieve a normally oriented mitotic axis, we cryosectioned
control and Atrx-null E13.5 embryos and scored the orientation of the mitotic spindle axis
relative to the ventricular surface in apical NPCs. Angular measurements of the mitotic
spindle were achieved by staining cryosections with the DNA counterstain DAPI in
conjunction with an antibody against the centrosomal marker γ-Tubulin, an indicator of
the mitotic spindle poles (Figure 4-1C). In control forebrains (n = 3), we observed that
in 84% of dividing cells, the mitotic spindles were oriented in a near-parallel (0-20°)
angle to the apical surface, only 63 % of dividing cells in the Atrx-null forebrain were
oriented in this manner. In contrast, mitotic apical NPCs in the Atrx-null forebrain (n =
3) were more frequently oriented in asymmetrically, with 25.3 % between 20-39° and
11.3 % between 40-90° relative to the apical surface, in contrast only 12% of control
NPCs were between 20-29° and 4% between 40-90°.
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Figure 4-1. Atrx-null neuroprogenitors exhibit mitotic defects in vitro and altered
cell division axis in vivo.
(A) Cultured neural progenitors from E13.5 control and Atrx-null forebrain were fixed,
immunostained with an anti-ATRX antibody and counterstained with DAPI to detect
DNA. (B) Mitotic cells were scored for mitotic defects (control n = 161 from 3 mice,
Atrx-null n = 114 from 4 mice), specifically for misaligned chromosomes at the
metaphase plate and chromosome bridges or lagging chromosomes at
anaphase/telophase. (C) Cryosections of E13.5 control and Atrx-null cortex were labeled
with anti-γ-Tubulin antibody to detect the centrosomes (arrowheads), and counterstained
with DAPI to detect DNA. The axis of neural progenitor cell division at the
neuroepithelial surface was measured using the axis between centrosomes (white dashed
line) relative to the neuroepithelial surface (red dashed line) (D) Orientation of the cell
division axis relative to the axis of the apical neuroepithelial surface was scored in
control and Atrx-null cortex (n = 50 cells/mouse, 3 mice/genotype). Scale in (A) & (C) =
10 µm.
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These findings demonstrate that dividing apical neuroprogenitors of the Atrx-null
embryonic forebrain were aligned more often in an asymmetric mode of cell division,
which may alter the inheritance of the apical plasma membrane and disturb the pattern of
neuronal differentiation.

4.3.3

Altered Cortical Architecture in the Postnatal Atrx-null
Forebrain

Our observation of increased asymmetrically oriented mitotic NPCs in the embryonic
Atrx-null neuroepithelium suggested a potential defect in the timing and balance of
projection neuron differentiation during this stage of neurogenesis. Our observation of
increased asymmetric cell divisions at E13.5 would initially cause an overproduction of
deep layer neurons (layers V-VI), eventually leading to a depletion of the progenitor pool
and thus reduced capacity to produce superficial layer neurons (Layers II-IV).

To test

this, we examined cortical lamination and the different neuronal subpopulations in the
Atrx-null P7 cortex, when most cortical neurons have been produced and have migrated
to their final laminar positions.

We first examined the status of the deep layer VI

neurons, which are born following the splitting of the preplate into the subplate and
marginal zone. Corticothalamic projection neurons of the deep cortical layer VI are
characterized by expression of the T-box transcription factor Tbr1 (Bulfone et al., 1995).
Consistent with increased asymmetric neurogenic cell divisions at E13.5, we found that
the postnatal Atrx-null cortex was characterized by an increased population of deep
cortical layer VI neurons, as assessed by immunofluorescence staining for Tbr1expressing cells (Control = 130.93 ± 20.37 cells, Atrx-null = 211.80 ± 27.18 cells, p <
0.01, n = 5) (Figure 4-2). In the Atrx-null cortex, this deep layer of Tbr1 expressing cells
was dramatically expanded along the dorsal-ventral axis (Control = 259.26 ± 34.94 µm,
Atrx-null = 352.78 ± 66.91 µm, p < 0.05, n = 5) (Figure 4-2). Surprisingly, total cortical
thickness was not significantly changed in this cortical region (Control = 754.09 ± 65.05
µm, Atrx-null = 767.46 ± 124.49 µm, p = 0.83, n = 5), though the depth of layer VI
relative to the entire depth of the cortex was significantly increased in the Atrx-null
forebrain (Figure 4-2). These results indicate a disproportionate increase in the number
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Figure 4-2. Cortical layer IV is expanded in the postnatal Atrx-null forebrain.
(A) Cortical sections at P7 from control and Atrx-null mice were stained with an antiTbr1 antibody to detect deep cortical layer VI projection neurons. (B) Results in (A) were
quantified by measuring the thickness of the domain of Tbr1 expressing deep cortical
layer neurons and total cortical thickness. Layer VI represents an increased proportion of
the total cortical depth in the Atrx-null mouse. Measurements were taken from 3 points
100 µm apart in 3 sequential sections per animal (n = 5 mice per genotype). The total
number of Tbr1 expressing cells in cortical layer VI is increased in the Atrx-null mouse,
along with the total number of layer VI cells (p < 0.01), as determined by DAPI
coutnerstaining. Cells counts were quantified from single 200 µm-wide columns
spanning the entire depth of the cortex from 3 sequential sections (n = 5 mice for both
control and Atrx-null genotypes). Scale in (A) = 200 µm. Error bars represent mean +/s.e.m. Single asterisk = P < 0.01. (C) Western blot analysis of total protein from P7
cortices shows an increase in the amount of Tbr1 protein in the Atrx-null (Null) forebrain
relative to the Foxg1Cre control (Ctrl) forebrain.
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of Tbr1 expressing neurons within the deep cortical layers of the postnatal Atrx-null
cortex. The expansion of layer VI and concurrent increase in the number of Tbr1expressing cells was confirmed by semi-quantitative Western Blot analysis of P7 cortex,
which showed an increase in Tbr1 protein levels in the Atrx-null cortex relative to control
samples (Fig 4-2C).

4.3.4

The Neural Progenitor Population is Reduced in the Late
Embryonic Atrx-null Cortex

Because we observed a dramatic increase in the number of Tbr1 expressing layer VI
cortical projection neurons in the P7 Atrx-null forebrain, in conjunction with an increase
in asymmetrically oriented neural progenitor cell divisions during mid-neurogenesis, we
theorized that the late-embryonic progenitor pool might be prematurely depleted as a
consequence. We investigated the populations of neural progenitor cells in E16.5 control
and Atrx-null forebrain by immunostaining cryosections with antibodies against the
transcription factors Pax6 and Tbr2, markers of apical and basal progenitors, respectively
(Figure 4-3). Both progenitor populations appeared reduced in the Atrx-null forebrain,
however the Tbr2 expressing basal progenitors were more severely affected. This effect
was consistent at both caudal (Figure 4-3A) and rostral (Figure 4-3B) cortical depths, and
affected both the dorsal cortical progenitors and hippocampal progenitors, consistent with
the hippocampus being a severely affected cerebral structure in the post-natal Atrx-null
forebrain. These results suggest that the overproduction of early born, deep cortical
projection neurons in the Atrx-null forebrain comes at the expense of the late-embryonic
neural progenitor population.

4.3.5

Superficial Cortical Projection Neurons are Depleted in the
Atrx-null Forebrain

The depletion of both neural progenitor populations at E16.5, especially of the basal
progenitor cells, suggested that the neural output during the later stages of neurogenesis
might be limited in the Atrx-null cortex. At E16.5, the projection neurons destined for the
most superficial cortical layers (II/III) are being produced, primarily by the basal
progenitor cells of the SVZ. The corticospinal projection neurons of cortical layer V
express high levels of the C2H2-type zinc finger transcription factor Ctip2. Control and
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Figure 4-3. Neural progenitor cells are depleted in the late-embryonic Atrx-null
cortex.
Cryosections of E16.5 control and Atrx-null forebrain were immunostained with
antibodies against Pax6 and Tbr2 to detect apical and basal neural progenitor cells,
respectively, at both rostral (A) and caudal (B) cortical depths. The Atrx-null cortex
shows a small reduction of Pax6 and more severe reduction of Tbr2 expressing cells in
the germinal VZ and SVZ. Scale in (A) & (B) = 200 µm.

119

Atrx-null P7 forebrain cryosections were immunostained with an antibody against Ctip2to
identify the projection neurons of layer V. Interestingly, we found no change in the
number of cells in layer V (Control: 113 ± 21.03 cells, Atrx-null 113.60 ± 19.23 cells, p =
0.98, n = 5), or Ctip2-positive cells in layer V (Control = 56.60 ± 9.61 cells, Atrx-null =
63.00 ± 12.25 cells, p = 0.38, n = 5), or of overall layer V thickness (Control: 228.11 ±
23.24 µm, Atrx-null: 199.37 ± 31.29 µm, p = 0.14, n = 5) however the entire layer was
shifted dorsally, possibly to accommodate the expansion of the deeper cortical layer VI
(Figure 4-4A, C)(Figure 4-2).

We next examined the status of the corticocortical

projection neurons of the superficial layers (II-IV) that express the class III POU domain
transcription factor Brn2.

Control and Atrx-null P7 forebrain cryosections were

immunostained with an antibody against Brn2 to identify superficial layer projection
neurons. Indeed, most Brn2 positive cells were observed in the superficial cortical region
corresponding to layer II-IV in both control and Atrx-null cortices (Fig 4-4A). In the
Atrx-null cortex, this upper layer (Cortical layers II-IV) of strong Brn2 expressing cells
was dramatically reduced in thickness along the dorsal-ventral axis (Control: 359.08 ±
42.49 µm, Atrx-null 256.63 ± 26.76 µm, p < 0.01, n = 5) (Fig 4-4B). This decrease in
layer thickness was accompanied by a reduction in the number of Brn2 expressing cells
within the superficial cortical layers (Control = 208.60 ± 45.97 cells, Atrx-null = 116.40 ±
31.41 cells, n = 5, p < 0.01) (Figure 4-4B). Together these results show that the Atrx-null
cortex is specifically depleted of late-born superficial cortical projection neurons.

4.4

Discussion

Using a conditional model of Atrx inactivation, we have shown altered cerebral cortical
patterning and neuron production in the post-natal Atrx-null mouse forebrain. In addition
we show that when cultured under proliferative conditions, NPCs isolated from the
embryonic Atrx-null cortex exhibit characteristic mitotic defects, including chromosome
misalignment at metaphase, and chromatin bridges at anaphase/telophase, supporting the
proposal that the DNA fragments observed in the embryonic lateral ventricles lining the
apical ventricular zone represent mitotic defects in vivo (Ritchie et al., 2008). We have
previously reported mitotic abnormalities in ATRX depleted HeLa cells, characterized by
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Figure 4-4. Superficial cortical layers are reduced in the Atrx-null cortex.
(A) Forebrain cryosections from P7 control and Atrx-null mice were immunostained with
antibodies against CTIP2 and BRN2. (B) Superficial cortical layers II-IV in the Atrx-null
mouse are thinner, and have a reduced number of BRN2+ cells (C) Cortical layer V is
unaffected in the Atrx-null mouse, showing conserved thickness, total cell number, and
CTIP2+ cell number. Measurements represent n = 5 mice per genotype. Single asterisk =
P<0.05, double asterisk= P<0.01. Error bars are mean ± s.e.m. Scale in (A) = 200 µm.
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chromosome congression defects during prometaphase, chromosome misalignment
during metaphase, and chromosome bridging during telophase/anaphase (Ritchie et al.,
2008). Taken together our data suggests that ATRX may regulate mitotic division in a
variety of cell types.
Loss of Atrx increased the proportion of apical progenitor cell divisions that exhibited
asymmetrically oriented mitotic spindles during early neurogenesis (E13.5), suggesting a
possible disruption of the normal timing of neuronal differentiation in the Atrx-null
cortex, as the mode of cell division is postulated to ultimately direct the choice of cell
differentiation or self-renewal. In the Atrx-null cortex at P7, cortical layer VI contained
significantly more cells and was much thicker along the dorsoventral axis compared to
equivalent control cortices, indicating an overproduction of early born deep-layer
neurons.

As these cells are produced during the early stages of cortical neurogenesis

(E11-E14), this observation supports the hypothesis that increased asymmetric apical
progenitor cell divisions during this period increases the amount of early neuronal
differentiation. Notably, the overall cell density of layer VI was unchanged in the Atrxnull mouse, suggesting that overall cell packing density was largely unaffected by loss of
ATRX expression. In contrast to the deep cortical layers, the superficial cortical layers
(Layers II-IV) of the Atrx-null cortex were significantly reduced in thickness along the
dorsal-ventral axis, and contained fewer superficial Brn2+ neurons. Upper cortical layer
neurons are produced during the later period of cortical neurogenesis (E14.5-E18.5), and
are derived primarily from neurogenic cell divisions of basal progenitors in the
embryonic subventricular zone.

In the Atrx-null cortex, excessive asymmetric cell

division during the early developmental stages might result in a consequent loss of lateborn superficial layer neurons due to the depletion of the late-stage population of cortical
progenitor cells in both the ventricular and subventricular zones. Immunostaining of the
late (E16.5) progenitor population showed a reduction in the domain of Pax6 and Tbr2expression in the progenitor populations in the ventricular and subventricular zones.
These results show that the late-embryonic apical (Pax6 positive) and basal (Tbr2
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positive) progenitor populations are depleted in the Atrx-null forebrain, likely as a
consequence of excessive neurogenesis during the early stages of development.
Studies of the primary microcephaly-associated gene cyclin-dependent kinase 5
regulatory subunits 2 (CDK5RAP2) have found that the forebrain of the knockout mouse
is severely dysmorphic, with cortical hypoplasia, and reduction in brain and hippocampal
size (Lizarraga et al., 2010). The cortex is characterized by a loss of later born superficial
layer (II/III) neurons and an increase in early born neurons of the deep cortical layer (VI),
a phenotype strikingly similar to that of the Atrx-null mouse, albeit more severe. The
neural progenitors of the embryonic cortex are characterized by mitotic defects, including
delayed mitotic progression and abnormal mitotic spindles with supernumerary spindle
poles, and increased levels of cell death. These progenitors also show defects in mitotic
spindle positioning, with an increase in the proportion of horizontal/asymmetric cell
divisions and a premature depletion of the neural progenitor cell population. A premature
increase in cell cycle exit in neural progenitors is predicted to increase the amount of
early born neurons, and decrease the amount of later born neurons in a predictable way
(Caviness et al., 2003), matching the observations in the cdk5rap2 deficient mouse, and
the Atrx-null mouse here.

Defects in spindle orientation have also been shown to

correlate with increased cell death during neuroepithelial stem cell divisions (Yingling et
al., 2008), pointing to a possible mechanism leading to the phenotype in the Atrx-null
forebrain.
It has recently been shown that ATRX partners with DAXX in the deposition the H3.3
histone variant at specific genomic loci, including telomeric repeats and pericentromeric
heterochromatin (Goldberg et al., 2010; Drané et al., 2010; Lewis et al., 2010).
Interestingly, reduced ATRX-dependent H3.3 deposition at pericentromeric chromatin
inhibits the expression of pericentromeric transcripts in mouse embryonic fibroblasts
(Drané et al., 2010). In fission yeast, these transcripts are required for the formation of
heterochromatin and sister chromatid cohesion (Zaratiegui et al., 2007), however a role in
mammalian cells remains unclear. The mitotic defects induced by Atrx disruption may
suggest that the incorporation of histone H3.3 is important for the organization and
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function of pericentromeric heterochromatin, with ramifications on mitotic division and
cell type ratios in the developing cerebral cortex.
These observations demonstrate a novel requirement for Atrx in the generation of specific
neuronal subtypes in the developing mouse cortex. Importantly, they show that Atrx is
required to maintain the appropriate level of symmetric neural progenitor cell divisions
during corticogenesis. The regulation of pericentromeric heterochromatin and mitotic
cell division by Atrx may be a critical feature in the control of neurogenesis, and may
help us understand the disease mechanisms related to ATRX deficiency.

4.5
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Chapter 5

5

General Discussion and Future Directions

The body of work presented in this thesis describes a novel role for the chromatin
remodeling protein ATRX in mitotic cell division and mammalian cortical neurogenesis.
Based on the results presented in chapters two and three, I conclude that ATRX is
required for normal mitotic progression, sister chromatid cohesion, and cytokinesis in
human somatic cells.

Furthermore, chapter four shows that in the developing mouse

brain, ATRX regulates cortical neurogenesis by maintaining mitotic fidelity in dividing
neuronal progenitor cells and promoting accurate symmetric proliferative cell divisions.

5.1

Thesis Summary

The ATRX protein belongs to the Snf2 family of chromatin remodeling proteins, and
although ATRX was originally presumed to function primarily as a transcriptional
regulator, my work has revealed a novel role for ATRX in mitotic cell division. In both
human and mouse cells, ATRX is enriched at the gene-sparse PCH domains throughout
the cell cycle, raising the possibility that it might have additional functions beyond
transcriptional control of gene expression. There, ATRX interacts with other factors
implicated in the establishment and maintenance of PCH, including HP1 (McDowell et
al., 1999), MeCP2 (Nan et al., 2007; Kernohan et al., 2010), Daxx (Xue et al., 2003), and
H3.3 (Goldberg et al., 2010; Wong et al., 2010; Drané et al., 2010; Lewis et al., 2010),
suggesting that it may also perform a specific function at this heterochromatic domain.
Proper assembly of PCH is required for normal centromere function and chromatid
cohesion during mitotic cell division, with disturbances leading to errors in chromosome
biorientation and segregation during mitosis.
In Chapter two, I tested the hypothesis that ATRX is required to maintain mitotic fidelity
in mammalian somatic cells. I found that RNAi mediated depletion of ATRX expression
in a human cancer cell line (HeLa) leads to increased levels of mitotic abnormalities,
including chromosome congression, alignment, and segregation errors. This phenotype
was accompanied by reduced sister-chromatid cohesion at metaphase, pointing to a
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potential mechanism underlying these defects.

Importantly, I reported evidence of

mitotic abnormalities in Atrx-null embryonic cortical neuronal progenitor cells in vivo,
suggesting that a requirement for ATRX in mitotic cell division might extend to a
physiologically relevant tissue.
In Chapter three, I reported a further disturbance of the terminal stages of mitotic cell
division in ATRX depleted HeLa cells, notably cytokinetic failure, multinucleation, and
cell death.

There were two possible explanations for this phenotype; firstly that

unresolved chromosome bridges or lagging chromosomes were inhibiting the cellular
cleavage through mechanical hindrance, or secondly, that the cytokinetic cleavage furrow
or midbody were functionally impaired, perhaps due to an unidentified role for ATRX in
regulating the expression of factors related to the function of these cellular structures. It
appears that the cytokinetic midbody and cleavage furrow are correctly assembled and
functional in these cells, suggesting that this phenotype may be a consequence of
chromosome segregation errors during mitosis.
In Chapter four, I investigated more thoroughly the effect of Atrx loss on neuronal
progenitor cell division and cerebral cortical organization and neurogenesis in the
developing mouse forebrain. I found that cultured neuronal progenitor cells from the
embryonic Atrx-null cortex displayed elevated levels of mitotic defects, including
chromosome misalignment on the metaphase spindle; reminiscent of the phenotype
observed in ATRX depleted HeLa cells. The apical neuronal progenitors within the
embryonic Atrx-null cortex were more often asymmetrically oriented during cell division,
suggesting an increase in neuronal differentiation. Consistent with these findings, the
postnatal Atrx-null cortex was characterized by a significant increase in early-born deep
cortical projection neurons.

Furthermore the late-embryonic neuronal progenitor

population was depleted, accompanied by a decrease in the late-born neurons of the
superficial cortical layers.

These findings specifically identify a functional role for

ATRX in cerebral cortical development, and contribute partly to the cortical phenotype of
the conditional Atrx-null mouse used in this study.

130

5.2

A Novel Function for ATRX in Cell Division

The initial goal of my research was to investigate a potential requirement of ATRX for
normal mitotic cell division by virtue of its seemingly ubiquitous enrichment at PCH in
both human and mouse somatic cells. To meet these ends I depleted HeLa cells of
ATRX using transient small interfering RNA (siRNA) and stable short hairpin RNA
(shRNA) mediated RNAi.

These experiments revealed a general mitotic defect in

proliferating ATRX deficient cells, associated with reduced chromatid cohesion and a
transient delay in mitotic progression. Other groups have also reported a requirement for
ATRX in normal meiotic progression. In the fully-grown mouse oocyte, ATRX is found
at PCH, and functional ablation in vitro using RNAi severely disrupts chromosome
alignment at the metaphase II (MII) meiotic spindle (De La Fuente et al., 2004). More
recently, further work showed that mouse oocytes depleted of ATRX by RNAi using a
stably expressing zona pellucida 3 (ZP3)-driven Atrx-short hairpin vector had
chromosome segregation defects with lagging chromosomes, loss of sister chromatid
cohesion at MII and greatly increased incidence of aneuploidy (Baumann et al., 2010).
Meiotic spindle abnormalities and faulty chromosome congression to the metaphase plate
are associated with advanced maternal age and are suspected of contributing to the
observed age-related increases of aneuploid eggs in humans (Battaglia et al., 1996). In
addition, an age-associated decrease in chromosome cohesion has also been reported, and
could also contribute to the observed increase in aneuploidy (Hodges et al., 2005).
Furthermore, a study by Pan et al. revealed that ATRX expression is reduced in eggs
obtained from old female mice, which have up to a 6-fold increase in hyperploidy,
associated with reduced fidelity of the metaphase I (MI) spindle assembly checkpoint
(SAC) (Pan et al., 2008).
Earlier this year, Bagheri-Fam et al. investigated the role of ATRX in testis development,
as ATR-X patients often display urogenital abnormalities, including small testis
(Bagheri-Fam et al., 2011). In this study, Atrx was conditionally inactivated in the
supporting cell lineage (Sertoli cells) of the mouse testis, and it was found that these Atrxnegative Sertoli cells exhibit prolonged G2/M phase, and elevated levels of apoptosis
during development, leading to tubule dysgenesis. However, it was not clear whether the
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decrease in cell viability was related to the mitotic delay or an alternative cause like
impaired cellular maturation.
In addition to broad developmental consequences, mitotic defects can be associated with
oncogenic events and tumorigenesis due to genomic instability (Montgomery et al.,
2003). To date there is no evidence that ATR-X patients exhibit mitotic defects or are
prone to developing cancer, however there is increasing evidence for a role of ATRX in
neoplasia outside of the context of ATR-X syndrome (Steensma et al., 2004). Recently,
ATRX and DAXX mutations were found in a large proportion of pancreatic
neuroendocrine tumours (PanNETS), suggesting that they have tumour suppressive
functions. Although rare, PanNETs are the second most common malignancy of the
pancreas, with a 10-year survival rate of only 40%. Exomic sequencing of 68 pancreatic
PanNETS identified mutations in both ATRX and Daxx in 17.6% (12/68) and 25%
(17/68) of the samples, respectively, but never together, suggesting that they act through
the same biological pathway in this context (Jiao et al., 2011). All ATRX mutations
correlated with loss of immunolabeling in these hyperplastic pancreatic islet cells,
suggesting that complete loss of ATRX protein is associated with oncogenetic events in
PanNETs.

Furthermore, another recent study of PanNETs found substantial

chromosomal alterations in 98% of samples (Hu et al., 2010), suggesting that genomic
instability could contribute to PanNET oncogenesis. It may be that null mutations in
ATRX lead to more severe genomic instability with a much higher propensity for
oncogenesis than hypomorphic mutations. Although I observed mitotic defects in human
cells retaining low levels of ATRX transcript (20% of control levels), both full-length and
ATRXt protein were not detectable using western blots analysis (see Figure 2-2),
suggesting that this approach may produce an effect more similar to a null-allele rather
than a hypomorphic allele.
A growing number of reports have now linked ATRX and cancer. In a study of 132
adults with de novo acute myeloid leukemia (AML), low ATRX expression correlated
with high-risk karyotype and poor clinical outcome (Serrano et al., 2006). Altered ATRX
expression levels have also been reported in gene expression profiling experiments using
prostate cancer primary cells (Coutinho-Camillo et al., 2006), esophageal squamous cell
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carcinoma cell lines (Bo et al., 2004), chronic lymphocytic leukemia primary cells, and
irradiated breast cancer cell lines (Roy et al., 2008).
Myelodysplastic syndromes (MDS) are a diverse group of neoplastic bone marrow
disorders, associated with a diverse array of cytogenetic abnormalities (Davids and
Steensma, 2010). Acquired somatic ATRX mutations were identified in the bone marrow
or blood cells of nearly all cases of alpha thalassemia myelodysplastic syndrome
(ATMDS) (Steensma et al., 2004), a pre-leukemic condition accompanied by alpha
thalassemia, typically observed in elderly men. It has not yet been determined whether
ATRX mutations in this context are the cause of the myeloproliferative syndrome, or are
acquired passenger mutations affecting only α-globin synthesis (Steensma et al., 2004;
Higgs and Weatherall, 2009). In some ATMDS cases, the α-thalassemia has been found
to be more severe than that associated with germline ATRX mutations, suggesting that
these somatic mutations may produce a null-allele, or that disparate mechanisms govern
this phenotype depending on the context of the mutation (Steensma et al., 2004).
Although ATRX deficiency induces a general mitotic or meiotic phenotype in some types
of actively dividing cells, the potential mechanisms leading to this defect have not yet
been determined. This may soon change after a number of recent reports identified a
novel role for ATRX, together with its binding partner DAXX, in the specific deposition
of H3.3 containing nucleosomes at discrete heterochromatic domains (Goldberg et al.,
2010; Wong et al., 2010), including PCH (Drané et al., 2010). Depletion of Atrx in MEFs
resulted in reduced H3.3 incorporation at pericentric repeats, and a decrease in the
abundance of pericentric transcripts (Drané et al., 2010). It is speculated that H3.3
facilitates transcription by reducing the stability of nucleosomes into which it is
incorporated, facilitating removal from the DNA template (Jin and Felsenfeld, 2007).
Interestingly, contrary to previous assumptions, the repetitive and heterochromatic
pericentric repeats are highly transcribed in fission yeast (Cam et al., 2005; Djupedal et
al., 2005) and mammals (Lu and Gilbert, 2007), and these transcripts are in fact required
for the formation of pericentric DNA as condensed heterochromatin through an RNAi
mediated mechanism (Maison et al., 2002; Djupedal et al., 2005).

Importantly,

pericentric heterochromatin structure is essential for kinetochore assembly (Gieni et al.,
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2008), centromeric cohesion (Nonaka et al., 2002), and accurate chromosome segregation
during mitosis (Peters et al., 2001; Pidoux and Allshire, 2004). In the ATRX depleted
HeLa cells described in my thesis, the kinetochore appears to be assembled properly as
CREST immunoreactivity [CREST is a human autoimmune anti-centromere antiserum,
predominantly detecting CENPA and CENPB (Brenner et al., 1981; Earnshaw and
Migeon, 1985)] appeared identical in control and ATRX deficient cells. Loss of the
H3K9me3 methyltransferase, Suv39h1, results in abnormal assembly of PCH, and
aberrant chromosome segregation and premature sister chromatid separation (Lehnertz et
al., 2003; García-Cao et al., 2004). This raises the possibility that the mitotic defects I
have described in ATRX compromised HeLa cells and mouse embryonic neuronal
progenitors are due to abnormal PCH assembly, perhaps due to the lack of H3.3
deposition and pericentric transcription, and subsequent failure to recruit or retain
appropriate amount of cohesin at PCH. To continue these studies, it will be important to
investigate the composition of PCH in these cells using immunofluorescence and ChIP
analysis to measure the presence of PCH antigens like HP1 and H3K9me3. In addition, it
would be useful to examine the level of pericentric repeat transcripts produced in these
cells, to confirm a disturbance in the RNAi-mediated pathway of PCH assembly. Other
studies conducted in the Bérubé lab have found that ATRX interacts with members of the
cohesin protein complex and recruits them to discrete gene regulatory regions of the
genome (Kernohan et al., 2010). A logical next step will be to determine whether ATRX
is required for the localization of cohesin to PCH in HeLa cells or cortical progenitors, as
this may provide a mechanism to explain the chromatid cohesion and mitotic defects. I
predict that ATRX is also required for normal enrichment of cohesin at PCH, as it is at
discrete gene loci. A chromatin ChIP approach to examine cohesin enrichment at the
human α-satellite or mouse major satellite pericentric repeats in ATRX deficient cells
could be used to address this question. To determine if this is a direct recruitment of
cohesin or an indirect mechanism through the maintenance of PCH structure by ATRX,
the domains of interaction between ATRX and cohesin will need to be identified.
Directed mutagenesis of ATRX and/or cohesin could be used to localize the interacting
regions, and in vivo reconstitution of these mutant isoforms could help distinguish
between these possibilities, for example if ATRX directly recruits cohesin to PCH,
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disrupting the interacting domains on either protein should lead to loss of recruitment. In
fission yeast, cohesin is primarily recruited to PCH by the HP1 homolog, Swi6 (Nonaka
et al., 2002). Because of the similarities in centromere regulation between mammals and
yeast, it was assumed that similar mechanisms of cohesin recruitment were active in both
systems. In fact, researchers have been unable to identify an interaction between cohesin
and mouse HP1 (Koch et al., 2008), suggesting that novel mechanisms of cohesin
recruitment may have evolved in the mammalian system (Gartenberg, 2009).
In Chapter three I presented evidence that ATRX-depletion induces cytokinetic
instability, whereby human cells depleted of ATRX more frequently fail cytokinesis,
producing multinucleated progeny. This phenotype may indicate a direct effect of ATRX
in the transcriptional regulation of genes required for the normal function of the
cytokinetic midbody or cleavage furrow, or a potential secondary effect of chromosome
instability during mitosis. To investigate this we conducted an examination of midbody
and cleavage furrow formation in these cells by immunostaining for specific proteins
associated with these cellular features, but were unable to identify any difference between
the control and ATRX depleted cells. However, this analysis was not exhaustive, and did
not include all potential protein targets involved in this complex process.

I would

continue this study by expanding the cohort of protein candidates to achieve a more
detailed profile of the cleavage furrow and cytokinetic midbody in ATRX deficient cells.
One protein candidate we investigated was Plk1, a serine/threonine kinase enriched at the
cytokinetic midzone during anaphase, telophase, and at the cytokinetic midbody. Elegant
studies using a selectively inhibitable Plk1 isoform have shown that Plk1 activity is
required for cleavage furrow formation (Burkard et al., 2007; Petronczki et al., 2007;
Santamaria et al., 2007; Brennan et al., 2007). It will be worthwhile to investigate the
recruitment of downstream Plk1 cofactors, such as RhoA, and the RhoA GTP exchange
factor ECT2, to the central spindle and midbody, to confirm that the Plk1 pathway is
intact in ATRX-deficient cells. The phenotype observed in the Atrx depleted HeLa cells
suggested a failure to complete the terminal stage of cytokinesis, a process known as
cellular abscission. Abscission is the least well-understood reaction in cytokinesis, but is
believed to involve membrane trafficking to remodel the midbody (Glotzer, 2001).
Therefore it may be informative to assess lipid membrane composition, focusing on the
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phospholipid phosphatidylethanolamine (PE), a required component of the lipid
membrane at the midbody (Emoto et al., 1996), and the syntaxin 2 membrane trafficking
proteins (Low et al., 2003), as the cytoplasmic membrane if often highly disorganized in
ATRX-depleted HeLa cells undergoing cytokinesis. Cytokinesis can also be blocked by
the presence of chromosome bridges that might signal via DNA damage response
pathways to block and reverse the ingression of the cleavage furrow, resulting in
aneuploidy or tetraploidy.

Because chromosome bridges were observed in ATRX-

depleted HeLa cells, and Atrx-null neuroprogenitors, it is possible that cytokinetic failure
is due strictly to chromosome nondisjunction. To investigate this, it would be important
to first examine the activation or post-translational modification of specific DNA-damage
signaling proteins such as BRCA2 phosphorylation, and Aurora B poly-ADPribosylation, both implicated in cytokinetic regulation [Reviewed in (Normand and King,
2010)].

5.3
ATRX and the Control of Cell Division in
Neurodevelopment
The severe developmental consequences of ATRX mutations on the human CNS highlight
the importance of characterizing the role of ATRX in mammalian neurodevelopment.
After observing mitotic defects in ATRX deficient human cells and mouse neuronal
progenitors, and because of the direct relationship connecting cell division and cortical
neurogenesis, I chose to investigate progenitor cell division in the conditional Atrx-null
mouse forebrain.
In Chapter four, I reported that apical neuronal progenitors in the embryonic Atrx-null
forebrain are more often oriented asymmetrically during cell division, suggesting an
increase in the proportion of neurogenic divisions during cortical development. It is
likely that abnormalities in the progression or completion of mitosis or cytokinesis in
these cells, such as in the ATRX depleted HeLa cells described in chapter two, promote
deviation of mitotic spindle positioning and/or cleavage furrow ingression, resulting in
aberrant mitotic orientation relative to the apical ventricular surface and altered cell fate
commitment. The murine animal model system has been used to identify a number of
genes that are specifically involved in neuronal progenitor cell division, many of which
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have human homologs associated with neurodevelopmental abnormalities, including
MCPH. One such gene is abnormal spindle microcephaly (ASPM), in which mutations
are the leading cause of human MCPH.

ASPM is localized to the spindle poles

(centrosomes) of mitotic cells (Fish et al., 2006; Higgins et al., 2010), and is
downregulated by apical neuronal progenitors undergoing neurogenic divisions (Fish et
al., 2006). Knockdown of ASPM expression using in vivo RNAi electroporation in
developing embryonic mouse forebrain resulted in more asymmetrically oriented mitotic
progenitor cells and an increase of non-progenitor daughter cell fate (Fish et al., 2006).
In addition, the products of the other characterized MCPH associated genes are also
centrosomal components, including CDK5RAP2, CENP-J, and Microcephalin,
suggesting a common mechanism linking mitotic regulation, neurogenesis, and cortical
size.
Striking results have been obtained from studies of one such MCPH-associated gene,
cyclin-dependent kinase 5 regulatory subunits 2 (CDK5RAP2), encoding a centrosomal
protein with a role in γ-tubulin ring complex (γ-TuRC) recruitment and microtubule
nucleation at the centrosome (Fong et al., 2008). Interestingly, this gene is mutated in the
Hertwig’s anemia (an) mouse line, where homozygous mutant animals have a
hypoproliferative anemia and leukopenia (Barker and Bernstein, 1983). These mice have
germ cell deficiencies with meiotic defects in embryonic germ cells and a high level of
spontaneous aneuploidy in primary cultures of hematopoietic fetal liver, bone marrow
and kidney epithelial cells (Eppig and Barker, 1984). More recently it was found that the
forebrain of this mouse is severely dysmorphic, with cortical hypoplasia, and reduction in
brain and hippocampal size (Lizarraga et al., 2010). The cortex is characterized by a loss
of later born superficial layer (II/III) neurons and an increase in early born neurons of the
deep cortical layer (VI), a phenotype strikingly similar to that of the Atrx-null mouse,
albeit more severe. The neuronal progenitors of the embryonic cortex are characterized
by mitotic defects, including delayed mitotic progression and abnormal mitotic spindles
with supernumerary spindle poles, and increased levels of cell death. These progenitors
also show defects in mitotic spindle positioning, with an increase in the proportion of
horizontal/asymmetric cell divisions and a premature depletion of the neuronal progenitor
cell population. Defects in spindle orientation have also been shown to correlate with
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increased cell death during neuroepithelial stem cell divisions (Yingling et al., 2008),
pointing to a possible mechanism leading to this phenotype in the Atrx-null forebrain. A
premature increase in cell cycle exit in neuronal progenitors is predicted to increase the
amount of early born neurons, and decrease the amount of later born neurons in a
predictable way (Caviness et al., 2003), matching the observations in the cdk5rap2
deficient mouse, as well as my results presented in chapter four.
Cytokinesis is also a critical step in the cellular control of cortical development,
exemplified by mutations in the CIT gene encoding the serine-threonine kinase Citron
(CitK).

Initial functional studies found that overexpression of truncation mutations

causes erratic cytokinetic behaviour and cytokinesis failure when overexpressed in HeLa
cells (Madaule et al., 2000).

Citron kinase is specifically found at the cytokinetic

midzone spindle and cleavage furrow during anaphase/telophase, where it then
translocates to the midbody during cytokinesis (Di Cunto et al., 1998; Eda et al., 2001).
The only known substrate of citron kinase is the regulatory light chain of myosin II, a
subunit of the ATP-dependent +-end actin motor protein that helps to organize actin
filaments into the contractile ring.

In rodent models, cit null mutations lead to

microcephaly, cellular binucleation, cytokinetic failure, and massive apoptosis in the
proliferative zones of the embryonic cortex (Di Cunto et al., 2000; Sarkisian et al., 2002).
Together these data demonstrate the critical role of cytokinetic regulation in cortical
development. Notably, the cortical phenotype of the Cit-null mouse is similar to that of
the conditional Atrx-null mouse studied in this thesis, with microcephaly, neuronal
apoptosis, and abnormal cell division. In addition to the phenotype described in Chapter
four, previous studies have shown that the embryonic Atrx-null cortex is also
characterized by elevated levels of p53-dependent apoptosis (Seah et al., 2008). It may
be that deficiency of ATRX in the developing cortex could lead to aneuploidy, which
could reduce cell viability and result in elevated apoptosis. It will be important for future
studies of the Atrx-null cortex to investigate the occurrence of neuronal binucleation in
vivo.
The Atrx-null forebrain used in this study retains normal expression of the truncated
ATRXt isoform. This isoform is not affected by the loxP-mediated recombination of
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Atrx exon 18, as this isoform naturally truncates at exon 11, producing a protein that
lacks the SWI/SNF homology domain. The function of ATRXt is not known, but it may
be useful to study a null allele of this isoform, or both isoforms in conjunction, to further
extend our understanding of the developmental and biological function of this gene. I
predict that a complete knockout of both alleles will be more severe than either single
allele in isolation, but might be difficult to study in the mouse if it leads to lethality when
induced in the developing brain. The RNAi-mediated depletion of ATRX in HeLa cells
described in chapter two targeted both full-length and ATRXt transcripts, therefore the
mitotic phenotype might also have been made more severe by a deficiency of both
proteins (versus only full length in the Atrx-null mouse). Furthermore, the Atrx-null
allele used here may produce a more profound effect than that of a more biologically
appropriate hypomorphic allele, because pathological mutations in ATRX are always
hypomorphic (with relation to ATR-X syndrome). This is supported by the observation
that somatic ATRX mutations associated with ATMDS can confer a more severe
hematological phenotype than inherited germline mutations associated with ATR-X
(Steensma et al., 2004). One explanation is that the somatic mutations produce nullalleles that would otherwise be developmentally lethal, but can be tolerated in a clonal
population of erythrocytes. However, since some mutations associated with this disparity
are identical to those found in ATR-X patients, who typically display less severe αthalassemia, other contributing factors must be important, for instance the polymorphic
G-rich VNTRs adjacent to the α-globin locus that are thought to be resolved by ATRX as
a means to regulate gene expression. Although the approaches presented in this thesis are
useful for the study of ATRX function, it will be important to introduce hypomorphic
patient mutations into the endogenous Atrx allele in the mouse followed by a study of
neurodevelopment to more accurately model the human disease.
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5.4
Proposed model: The Role of ATRX in Mitosis and
Neurogenesis
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Figure 5-1. Proposed model of ATRX function in mitosis and neurogenesis.
(A) In mammalian somatic cells, ATRX is required for normal sister chromatid cohesion,
possibly through the recruitment of the cohesin protein complex to pericentromeric
heterochromatin (PCH). In ATRX-deficient cells, cohesin occupancy (or function) might
be disrupted at PCH, resulting in reduced centromeric sister chromatid cohesion. During
mitosis in ATRX-deficient cells, the spindle microtubules exert a force on the
kinetochores, pulling the sister chromatids towards opposing centrosomes prematurely,
resulting in mitotic defects. (B) In the embryonic Atrx-null mouse cortex, mitotic neural
progenitors in the neuroepithelium, which line the lateral ventricles, are less often
symmetrically oriented during cell division, suggesting abnormally elevated levels of
neurogenic cell division. Mitotic abnormalities due to loss of ATRX-dependent sister
chromatid cohesion might disrupt the precise symmetric orientation of the mitotic
spindle. The postnatal Atrx-null cortex is characterized by an expansion of the deep
cortical layers and a reduction of the superficial cortical layers, suggesting excessive
production of early-born deep-layer neurons at the expense of later-born superficial layer
neurons, consistent with excessive neuron production during the earlier stages of
neurogenesis.
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5.5

Concluding Remarks

The work presented in this thesis identifies a novel role for the Snf2 chromatin
remodeling protein in the process of mitotic cell division both in cultured human cells
and in the neuronal progenitors of the developing mouse brain. The observation that
ATRX depleted cells exhibit chromatid cohesion defects contributes to the rapidly
expanding role for ATRX at constitutively condensed pericentromeric heterochromatin.
In addition to regulating the expression of a subset of genes, different lines of research
now point to a likely role for ATRX in maintaining the structure and function of PCH.
Together with the growing list of malignancies associated with somatic ATRX mutations,
these data suggest a possible mechanism contributing to genomic instability in certain
cases of severe ATRX deficiency. Furthermore, ATRX now joins a growing list of genes
that are implicated in neurodevelopment through the regulation of cell division.
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